BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 771770 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)C(C)C InChI=1S/C19H37N3O4S/c1-5-20-19(23)22-12-6-7-17(21-27(4,24)25)18(22)13-26-16-10-8-15(9-11-16)14(2)3/h14-18,21H,5-13H2,1-4H3,(H,20,23)/t15-,16+,17-,18-/m0/s1 QVBNNVDWURLGGQ-MHORFTMASA-N 386064 (2R,3S)-N-ethyl-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxamide::US10287305, Example 104::US10287305, Example 2::US10508083, Example 104::US11292766, Example 104 Orexin receptor type 2 Homo sapiens 1.90 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386064 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386064&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312469 404855223 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771771 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C19H30N2O3S/c1-25(22,23)21-18-8-5-13-20-19(18)14-24-17-11-9-16(10-12-17)15-6-3-2-4-7-15/h2-4,6-7,16-21H,5,8-14H2,1H3/t16-,17+,18-,19-/m0/s1 GWXIWAAZEKCXMJ-RDGPPVDQSA-N 386065 N-((2R,3S)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 3::US10287305, Example 333::US10508083, Example 333::US11292766, Example 333 Orexin receptor type 2 Homo sapiens 540 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386065&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310078 404855224 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771772 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C21H32N2O4S/c1-16(24)23-14-6-9-20(22-28(2,25)26)21(23)15-27-19-12-10-18(11-13-19)17-7-4-3-5-8-17/h3-5,7-8,18-22H,6,9-15H2,1-2H3/t18-,19+,20-,21-/m0/s1 JYJTZUGIUWJJIK-WOZUAGRISA-N 386066 N-((2R,3S)-1-acetyl-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 4::US10508083, Example 4::US11292766, Example 4 Orexin receptor type 2 Homo sapiens 44.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386066 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386066&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310087 404855225 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771773 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C21H32N2O5S/c1-27-21(24)23-14-6-9-19(22-29(2,25)26)20(23)15-28-18-12-10-17(11-13-18)16-7-4-3-5-8-16/h3-5,7-8,17-20,22H,6,9-15H2,1-2H3/t17-,18+,19-,20-/m0/s1 UXZAJSZFFARTEI-YRPNKDGESA-N 386067 US10287305, Example 5::US10508083, Example 191::US11292766, Example 191::methyl (2R,3S)-3- ((methylsulfonyl)amino)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidine-1-carboxylate Orexin receptor type 2 Homo sapiens 2.20 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386067&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search A6F 7SR8,7SQO 130310079 404855226 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771774 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1cc(F)cc(F)c1 InChI=1S/C19H28F2N2O3S/c1-27(24,25)23-18-3-2-8-22-19(18)12-26-17-6-4-13(5-7-17)14-9-15(20)11-16(21)10-14/h9-11,13,17-19,22-23H,2-8,12H2,1H3/t13-,17+,18-,19-/m0/s1 DATADCLNOZHNAB-PZGXJPJSSA-N 386068 N-((2R,3S)-2-(((cis-4-(3,5- difluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 7::US10508083, Example 7::US11292766, Example 7 Orexin receptor type 2 Homo sapiens 250 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386068&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310092 404855227 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771775 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cc(F)cc(F)c1 InChI=1S/C21H30F2N2O4S/c1-14(26)25-9-3-4-20(24-30(2,27)28)21(25)13-29-19-7-5-15(6-8-19)16-10-17(22)12-18(23)11-16/h10-12,15,19-21,24H,3-9,13H2,1-2H3/t15-,19+,20-,21-/m0/s1 UXDYZLFWHWIPME-ZFCZOSEKSA-N 386069 N-((2R,3S)-1-acetyl-2-(((cis-4- (3,5- difluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 8::US10508083, Example 8::US11292766, Example 8 Orexin receptor type 2 Homo sapiens 5.60 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386069 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386069&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310080 404855228 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771776 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1cc(F)ccc1F InChI=1S/C19H28F2N2O3S/c1-27(24,25)23-18-3-2-10-22-19(18)12-26-15-7-4-13(5-8-15)16-11-14(20)6-9-17(16)21/h6,9,11,13,15,18-19,22-23H,2-5,7-8,10,12H2,1H3/t13-,15+,18-,19-/m0/s1 ZIXQWHRFFSLKIG-UAFONNFLSA-N 386070 N-((2R,3S)-2-(((cis-4-(2,5- difluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 10::US10508083, Example 10::US11292766, Example 10 Orexin receptor type 2 Homo sapiens 220 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386070 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386070&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310081 404855229 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771777 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cc(F)ccc1F InChI=1S/C21H30F2N2O5S/c1-29-21(26)25-11-3-4-19(24-31(2,27)28)20(25)13-30-16-8-5-14(6-9-16)17-12-15(22)7-10-18(17)23/h7,10,12,14,16,19-20,24H,3-6,8-9,11,13H2,1-2H3/t14-,16+,19-,20-/m0/s1 QDCQATOYWNLFAU-ZXUOCUECSA-N 386071 US10287305, Example 11::US10508083, Example 11::US11292766, Example 11::methyl (2R,3S)-2-(((cis-4-(2,5- difluorophenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386071&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310083 404855230 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771778 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1c(F)cccc1F InChI=1S/C19H28F2N2O3S/c1-27(24,25)23-17-6-3-11-22-18(17)12-26-14-9-7-13(8-10-14)19-15(20)4-2-5-16(19)21/h2,4-5,13-14,17-18,22-23H,3,6-12H2,1H3/t13-,14+,17-,18-/m0/s1 GEMQYTQUWYZBDM-DACLVMHWSA-N 386072 N-((2R,3S)-2-(((cis-4-(2,6- difluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 13::US10508083, Example 13::US11292766, Example 13 Orexin receptor type 2 Homo sapiens 130 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386072&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310082 404855231 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771779 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1c(F)cccc1F InChI=1S/C21H30F2N2O4S/c1-14(26)25-12-4-7-19(24-30(2,27)28)20(25)13-29-16-10-8-15(9-11-16)21-17(22)5-3-6-18(21)23/h3,5-6,15-16,19-20,24H,4,7-13H2,1-2H3/t15-,16+,19-,20-/m0/s1 BMGJYYNZHHFBJJ-JSJNYSNDSA-N 386073 N-((2R, 3S)-1-acetyl-2-(((cis-4- (2,6- difluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 14::US10508083, Example 14::US11292766, Example 14 Orexin receptor type 2 Homo sapiens 6.60 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386073&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310084 404855232 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771780 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1cccc(F)c1 InChI=1S/C19H29FN2O3S/c1-26(23,24)22-18-6-3-11-21-19(18)13-25-17-9-7-14(8-10-17)15-4-2-5-16(20)12-15/h2,4-5,12,14,17-19,21-22H,3,6-11,13H2,1H3/t14-,17+,18-,19-/m0/s1 ZCWZWZYQZABHDJ-VLQPXKRTSA-N 386074 N-((2R,3S)-2-(((cis-4-(3- fluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 15::US10508083, Example 15::US11292766, Example 15 Orexin receptor type 2 Homo sapiens 280 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386074 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386074&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310088 404855233 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771781 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1cccc(F)c1)C(=O)C1CC1 InChI=1S/C23H33FN2O4S/c1-31(28,29)25-21-6-3-13-26(23(27)17-7-8-17)22(21)15-30-20-11-9-16(10-12-20)18-4-2-5-19(24)14-18/h2,4-5,14,16-17,20-22,25H,3,6-13,15H2,1H3/t16-,20+,21-,22-/m0/s1 BSZKBFQXXVTZBO-AEMJNJESSA-N 386075 N-((2R,3S)-1-(cyclopropylcarbonyl)- 2-(((cis-4-(3- fluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 16::US10508083, Example 16::US11292766, Example 16 Orexin receptor type 2 Homo sapiens 0.840 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386075&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310089 404855234 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771782 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1cccc(F)c1F InChI=1S/C19H28F2N2O3S/c1-27(24,25)23-17-6-3-11-22-18(17)12-26-14-9-7-13(8-10-14)15-4-2-5-16(20)19(15)21/h2,4-5,13-14,17-18,22-23H,3,6-12H2,1H3/t13-,14+,17-,18-/m0/s1 AHHVMXBZXYMRMU-DACLVMHWSA-N 386076 N-((2R,3S)-2-(((cis-4-(2,3- difluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 18::US10508083, Example 18::US11292766, Example 18 Orexin receptor type 2 Homo sapiens 520 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386076&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310085 404855235 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771783 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(F)c1F InChI=1S/C21H30F2N2O4S/c1-14(26)25-12-4-7-19(24-30(2,27)28)20(25)13-29-16-10-8-15(9-11-16)17-5-3-6-18(22)21(17)23/h3,5-6,15-16,19-20,24H,4,7-13H2,1-2H3/t15-,16+,19-,20-/m0/s1 YOEHEHOSLLVDHQ-JSJNYSNDSA-N 386077 N-((2R,3S)-1-acetyl-2-(((cis-4- (2,3- difluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 19::US10508083, Example 19::US11292766, Example 19 Orexin receptor type 2 Homo sapiens 12.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386077&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310086 404855236 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771784 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(F)c1F InChI=1S/C21H30F2N2O5S/c1-29-21(26)25-12-4-7-18(24-31(2,27)28)19(25)13-30-15-10-8-14(9-11-15)16-5-3-6-17(22)20(16)23/h3,5-6,14-15,18-19,24H,4,7-13H2,1-2H3/t14-,15+,18-,19-/m0/s1 JREDPNDILVRUBV-QXGSTGNESA-N 386078 US10287305, Example 20::US10508083, Example 20::US11292766, Example 20::methyl (2R,3S)-2-(((cis-4-(2,3- difluorophenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 3.40 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386078&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310099 404855237 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771785 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1c(F)ccc(F)c1F InChI=1S/C19H27F3N2O3S/c1-28(25,26)24-16-3-2-10-23-17(16)11-27-13-6-4-12(5-7-13)18-14(20)8-9-15(21)19(18)22/h8-9,12-13,16-17,23-24H,2-7,10-11H2,1H3/t12-,13+,16-,17-/m0/s1 REOONBLHEVHLQF-RMHZUWNSSA-N 386079 N-((2R,3S)-2-(((cis-4-(2,3,6- trifluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 21::US10508083, Example 21::US11292766, Example 21 Orexin receptor type 2 Homo sapiens 200 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386079&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310090 404855238 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771786 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1c(F)ccc(F)c1F InChI=1S/C21H29F3N2O4S/c1-13(27)26-11-3-4-18(25-31(2,28)29)19(26)12-30-15-7-5-14(6-8-15)20-16(22)9-10-17(23)21(20)24/h9-10,14-15,18-19,25H,3-8,11-12H2,1-2H3/t14-,15+,18-,19-/m0/s1 MNFYUJYODLNFLH-QXGSTGNESA-N 386080 N-((2R,3S)-1-acetyl-2-(((cis-4- (2,3,6- trifluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 22::US10508083, Example 22::US11292766, Example 22 Orexin receptor type 2 Homo sapiens 5.30 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386080&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310093 404855239 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771787 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1C(F)(F)F InChI=1S/C20H29F3N2O3S/c1-29(26,27)25-18-7-4-12-24-19(18)13-28-15-10-8-14(9-11-15)16-5-2-3-6-17(16)20(21,22)23/h2-3,5-6,14-15,18-19,24-25H,4,7-13H2,1H3/t14-,15+,18-,19-/m0/s1 KSRKXJHLVAZXQW-QXGSTGNESA-N 386081 N-((2R,3S)-2-(((cis-4-(2- (trifluoromethyl)phenyl)- cyclohexyl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 23::US10508083, Example 23::US11292766, Example 23 Orexin receptor type 2 Homo sapiens 1200 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386081&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310091 404855240 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771788 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1C(F)(F)F InChI=1S/C22H31F3N2O4S/c1-15(28)27-13-5-8-20(26-32(2,29)30)21(27)14-31-17-11-9-16(10-12-17)18-6-3-4-7-19(18)22(23,24)25/h3-4,6-7,16-17,20-21,26H,5,8-14H2,1-2H3/t16-,17+,20-,21-/m0/s1 BCZCQWJAFVHSSJ-JWWGGVBKSA-N 386082 N-((2R,3S)-1-acetyl-2-(((cis-4-(2- (trifluoromethyl)phenyl)- cyclohexyl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 24::US10508083, Example 24::US11292766, Example 24 Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386082 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386082&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310094 404855241 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771789 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1cccc(F)c1F)C(=O)CO InChI=1S/C21H30F2N2O5S/c1-31(28,29)24-18-6-3-11-25(20(27)12-26)19(18)13-30-15-9-7-14(8-10-15)16-4-2-5-17(22)21(16)23/h2,4-5,14-15,18-19,24,26H,3,6-13H2,1H3/t14-,15+,18-,19-/m0/s1 FUPCUOPGOMMRON-QXGSTGNESA-N 386083 N-((2R,3S)-2-(((cis-4-(2,3- difluorophenyl)cyclohexyl)oxy)- methyl)-1-glycoloylpiperidin-3- yl)methanesulfonamide::US10287305, Example 25::US10508083, Example 25::US11292766, Example 25 Orexin receptor type 2 Homo sapiens 7.90 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386083&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310100 404855242 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771790 COc1ccccc1[C@@H]1CC[C@@H](CC1)OC[C@@H]1NCCC[C@@H]1NS(C)(=O)=O InChI=1S/C20H32N2O4S/c1-25-20-8-4-3-6-17(20)15-9-11-16(12-10-15)26-14-19-18(7-5-13-21-19)22-27(2,23)24/h3-4,6,8,15-16,18-19,21-22H,5,7,9-14H2,1-2H3/t15-,16+,18-,19-/m0/s1 FJHULEFVSHHNCH-NBMJBFSESA-N 386085 N-((2R,3S)-2-(((cis-4-(2- methoxyphenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 27::US10508083, Example 27::US11292766, Example 27 Orexin receptor type 2 Homo sapiens 310 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386085&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310095 404855244 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771791 COc1ccccc1[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)C1CC1)NS(C)(=O)=O InChI=1S/C24H36N2O5S/c1-30-23-8-4-3-6-20(23)17-11-13-19(14-12-17)31-16-22-21(25-32(2,28)29)7-5-15-26(22)24(27)18-9-10-18/h3-4,6,8,17-19,21-22,25H,5,7,9-16H2,1-2H3/t17-,19+,21-,22-/m0/s1 AGFAYTQJGDVPLE-TZEULACYSA-N 386086 N-((2R,3S)-1-(cyclopropylcarbonyl)- 2-(((cis-4-(2- methoxyphenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 28::US10508083, Example 28::US11292766, Example 28 Orexin receptor type 2 Homo sapiens 2.70 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386086&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310097 404855245 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771792 CC(C)OC(=O)N1CCC[C@H](NS(=O)(=O)N(C)C)[C@@H]1COC1CCN(CC1)c1ncccn1 InChI=1S/C21H36N6O5S/c1-16(2)32-21(28)27-12-5-7-18(24-33(29,30)25(3)4)19(27)15-31-17-8-13-26(14-9-17)20-22-10-6-11-23-20/h6,10-11,16-19,24H,5,7-9,12-15H2,1-4H3/t18-,19-/m0/s1 YQNKRWPIJMZRDB-OALUTQOASA-N 386087 US10287305, Example 29::US10508083, Example 29::US11292766, Example 29::isopropyl cis-3- ((dimethylsulfamoyl)amino)-2- (((1-(pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidine-1- carboxylate Orexin receptor type 2 Homo sapiens 17.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386087 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386087&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310101 404855246 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771793 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C22H35N3O4S/c1-3-23-22(26)25-15-7-10-20(24-30(2,27)28)21(25)16-29-19-13-11-18(12-14-19)17-8-5-4-6-9-17/h4-6,8-9,18-21,24H,3,7,10-16H2,1-2H3,(H,23,26)/t18-,19+,20-,21-/m0/s1 GCSPLXQGOXYDRB-WOZUAGRISA-N 386088 (2R,3S)-N-ethyl-3- ((methylsulfonyl)amino)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidine-1-carboxamide::US10287305, Example 30::US10508083, Example 30::US11292766, Example 30 Orexin receptor type 2 Homo sapiens 0.110 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386088&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310098 404855247 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771794 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)C1CC1 InChI=1S/C23H34N2O4S/c1-30(27,28)24-21-8-5-15-25(23(26)19-9-10-19)22(21)16-29-20-13-11-18(12-14-20)17-6-3-2-4-7-17/h2-4,6-7,18-22,24H,5,8-16H2,1H3/t18-,20+,21-,22-/m0/s1 QKNVZUHNSSFEOK-FKVLARQCSA-N 386089 N-((2R,3S)-1-(cyclopropylcarbonyl)- 2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 31::US10508083, Example 31::US11292766, Example 31 Orexin receptor type 2 Homo sapiens 0.660 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386089&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310102 404855248 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771795 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1C(F)(F)F InChI=1S/C22H31F3N2O5S/c1-31-21(28)27-13-5-8-19(26-33(2,29)30)20(27)14-32-16-11-9-15(10-12-16)17-6-3-4-7-18(17)22(23,24)25/h3-4,6-7,15-16,19-20,26H,5,8-14H2,1-2H3/t15-,16+,19-,20-/m0/s1 SUPRYJDQUWCCTP-JSJNYSNDSA-N 386091 US10287305, Example 32::US10508083, Example 32::US11292766, Example 32::methyl (2R,3S)-3- ((methylsulfonyl)amino)-2-(((cis-4- (2-(trifluoromethyl)phenyl)- cyclohexyl)oxy)methyl)piperidine-1- carboxylate Orexin receptor type 2 Homo sapiens 15.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386091&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310104 404855250 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771796 CCS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)C(C)C)C(C)=O InChI=1S/C19H36N2O4S/c1-5-26(23,24)20-18-7-6-12-21(15(4)22)19(18)13-25-17-10-8-16(9-11-17)14(2)3/h14,16-20H,5-13H2,1-4H3/t16-,17+,18-,19-/m0/s1 BXCHBUYDFXKLTP-RDGPPVDQSA-N 386094 N-((2R,3S)-1-acetyl-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)ethanesulfonamide::US10287305, Example 33::US10508083, Example 33::US11292766, Example 33 Orexin receptor type 2 Homo sapiens 68.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386094&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310103 404855253 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771797 CCCC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)C(C)C InChI=1S/C20H38N2O4S/c1-5-7-20(23)22-13-6-8-18(21-27(4,24)25)19(22)14-26-17-11-9-16(10-12-17)15(2)3/h15-19,21H,5-14H2,1-4H3/t16-,17+,18-,19-/m0/s1 WRICHQCWYXCMRS-RDGPPVDQSA-N 386095 N-(cis-1-butyryl-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 35::US10508083, Example 35::US11292766, Example 35 Orexin receptor type 2 Homo sapiens 93.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386095&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310106 404855254 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771798 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1S(C)(=O)=O)NS(C)(=O)=O InChI=1S/C17H34N2O5S2/c1-13(2)14-7-9-15(10-8-14)24-12-17-16(18-25(3,20)21)6-5-11-19(17)26(4,22)23/h13-18H,5-12H2,1-4H3/t14-,15+,16-,17-/m0/s1 WUHKVQYRDRCVME-YVSFHVDLSA-N 386096 N-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1- (methylsulfonyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 36::US10508083, Example 36::US11292766, Example 36 Orexin receptor type 2 Homo sapiens 880 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386096&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310107 404855255 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771799 CCS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@@H]1CC[C@H](C)CC1)C(=O)Nc1ccccc1 InChI=1S/C22H35N3O4S/c1-3-30(27,28)24-20-10-7-15-25(22(26)23-18-8-5-4-6-9-18)21(20)16-29-19-13-11-17(2)12-14-19/h4-6,8-9,17,19-21,24H,3,7,10-16H2,1-2H3,(H,23,26)/t17-,19+,20-,21-/m0/s1 FRZSBOLMXFUBOY-NRDMVMEKSA-N 386097 US10287305, Example 37::US10508083, Example 37::US11292766, Example 37::cis-3-((ethylsulfonyl)amino)-2- (((cis-4- methylcyclohexyl)oxy)methyl)-N- phenylpiperidine-1-carboxamide Orexin receptor type 2 Homo sapiens 880 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386097 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386097&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310108 404855256 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771800 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)N1CCCC1)NS(C)(=O)=O InChI=1S/C21H39N3O4S/c1-16(2)17-8-10-18(11-9-17)28-15-20-19(22-29(3,26)27)7-6-14-24(20)21(25)23-12-4-5-13-23/h16-20,22H,4-15H2,1-3H3/t17-,18+,19-,20-/m0/s1 MRAXJCWWMJBFHA-YRPNKDGESA-N 386100 N-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1- (pyrrolidin-1-ylcarbonyl)piperidin- 3-yl)methanesulfonamide::US10287305, Example 39::US10508083, Example 39::US11292766, Example 39 Orexin receptor type 2 Homo sapiens 940 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386100 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386100&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310110 404855259 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771801 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)N(C)C)NS(C)(=O)=O InChI=1S/C19H37N3O4S/c1-14(2)15-8-10-16(11-9-15)26-13-18-17(20-27(5,24)25)7-6-12-22(18)19(23)21(3)4/h14-18,20H,6-13H2,1-5H3/t15-,16+,17-,18-/m0/s1 YGTJIUHWJYMMKI-MHORFTMASA-N 386101 US10287305, Example 40::US10508083, Example 40::US11292766, Example 40::cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)- N,N-dimethyl-3- ((methylsulfonyl)amino)piperidine- 1-carboxamide Orexin receptor type 2 Homo sapiens 720 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386101&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310111 404855260 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771802 CCOC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)C(C)C InChI=1S/C19H36N2O5S/c1-5-25-19(22)21-12-6-7-17(20-27(4,23)24)18(21)13-26-16-10-8-15(9-11-16)14(2)3/h14-18,20H,5-13H2,1-4H3/t15-,16+,17-,18-/m0/s1 KODFSLAYJFFNGG-MHORFTMASA-N 386102 US10287305, Example 42::US10508083, Example 42::US11292766, Example 42::ethyl cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 210 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386102&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310113 404855261 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771803 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)Oc1ccccc1)NS(C)(=O)=O InChI=1S/C23H36N2O5S/c1-17(2)18-11-13-19(14-12-18)29-16-22-21(24-31(3,27)28)10-7-15-25(22)23(26)30-20-8-5-4-6-9-20/h4-6,8-9,17-19,21-22,24H,7,10-16H2,1-3H3/t18-,19+,21-,22-/m0/s1 HMWZHSIIIYBKOM-MXNKGDRCSA-N 386103 US10287305, Example 43::US10508083, Example 43::US11292766, Example 43::phenyl cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine-1- carboxylate Orexin receptor type 2 Homo sapiens 1100 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386103&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310114 404855262 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771804 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)COc1ccccc1)NS(C)(=O)=O InChI=1S/C24H38N2O5S/c1-18(2)19-11-13-21(14-12-19)30-16-23-22(25-32(3,28)29)10-7-15-26(23)24(27)17-31-20-8-5-4-6-9-20/h4-6,8-9,18-19,21-23,25H,7,10-17H2,1-3H3/t19-,21+,22-,23-/m0/s1 KMNDFYBJPHUJJD-MALNDZBISA-N 386104 N-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1- (phenoxyacetyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 44::US10508083, Example 44::US11292766, Example 44 Orexin receptor type 2 Homo sapiens 1300 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386104 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386104&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310115 404855263 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771805 COCC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)C(C)C InChI=1S/C19H36N2O5S/c1-14(2)15-7-9-16(10-8-15)26-12-18-17(20-27(4,23)24)6-5-11-21(18)19(22)13-25-3/h14-18,20H,5-13H2,1-4H3/t15-,16+,17-,18-/m0/s1 NTBGARRLKDSVGU-MHORFTMASA-N 386109 N-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1- (methoxyacetyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 45::US10508083, Example 45::US11292766, Example 45 Orexin receptor type 2 Homo sapiens 330 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386109&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310117 404855268 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771806 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)COC(C)=O)NS(C)(=O)=O InChI=1S/C20H36N2O6S/c1-14(2)16-7-9-17(10-8-16)28-12-19-18(21-29(4,25)26)6-5-11-22(19)20(24)13-27-15(3)23/h14,16-19,21H,5-13H2,1-4H3/t16-,17+,18-,19-/m0/s1 GHIHXHGHENGAIU-RDGPPVDQSA-N 386110 2-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidin-1-yl)- 2-oxoethyl acetate::US10287305, Example 47::US10508083, Example 47::US11292766, Example 47 Orexin receptor type 2 Homo sapiens 60.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386110&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310116 404855269 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771807 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)C(C)(C)C)NS(C)(=O)=O InChI=1S/C21H40N2O4S/c1-15(2)16-9-11-17(12-10-16)27-14-19-18(22-28(6,25)26)8-7-13-23(19)20(24)21(3,4)5/h15-19,22H,7-14H2,1-6H3/t16-,17+,18-,19-/m0/s1 RWRREBZZLXYOQC-RDGPPVDQSA-N 386111 N-(cis-1-(2,2-dimethylpropanoyl)-2- (((cis-4- isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 53::US10508083, Example 53::US11292766, Example 53 Orexin receptor type 2 Homo sapiens 980 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386111&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310124 404855270 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771808 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)CCc1ccccc1)NS(C)(=O)=O InChI=1S/C25H40N2O4S/c1-19(2)21-12-14-22(15-13-21)31-18-24-23(26-32(3,29)30)10-7-17-27(24)25(28)16-11-20-8-5-4-6-9-20/h4-6,8-9,19,21-24,26H,7,10-18H2,1-3H3/t21-,22+,23-,24-/m0/s1 GYYBDAITWPSUTP-KIHHCIJBSA-N 386112 N-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1-(3- phenylpropanoyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 54::US10508083, Example 54::US11292766, Example 54 Orexin receptor type 2 Homo sapiens 4100 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386112&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310125 404855271 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771809 COC(=O)CCC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)C(C)C InChI=1S/C21H38N2O6S/c1-15(2)16-7-9-17(10-8-16)29-14-19-18(22-30(4,26)27)6-5-13-23(19)20(24)11-12-21(25)28-3/h15-19,22H,5-14H2,1-4H3/t16-,17+,18-,19-/m0/s1 SLYDAKFCMIBLCG-RDGPPVDQSA-N 386114 US10287305, Example 55::US10508083, Example 55::US11292766, Example 55::methyl 4-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidin-1-yl)- 4-oxobutanoate Orexin receptor type 2 Homo sapiens 140 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386114&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310126 404855273 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771810 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)C1CCOCC1)NS(C)(=O)=O InChI=1S/C22H40N2O5S/c1-16(2)17-6-8-19(9-7-17)29-15-21-20(23-30(3,26)27)5-4-12-24(21)22(25)18-10-13-28-14-11-18/h16-21,23H,4-15H2,1-3H3/t17-,19+,20-,21-/m0/s1 IFLXMSQIIVKANH-NRDMVMEKSA-N 386115 N-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1- (tetrahydro-2H-pyran-4- ylcarbonyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 60::US10508083, Example 60::US11292766, Example 60 Orexin receptor type 2 Homo sapiens 140 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386115&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310131 404855274 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771811 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1S(=O)(=O)C1CC1)NS(C)(=O)=O InChI=1S/C19H36N2O5S2/c1-14(2)15-6-8-16(9-7-15)26-13-19-18(20-27(3,22)23)5-4-12-21(19)28(24,25)17-10-11-17/h14-20H,4-13H2,1-3H3/t15-,16+,18-,19-/m0/s1 LEUOIWVMKNLZFA-NBMJBFSESA-N 386116 N-(cis-1-(cyclopropylsulfonyl)-2-(((cis- 4-isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 62::US10508083, Example 62::US11292766, Example 62 Orexin receptor type 2 Homo sapiens 2300 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386116&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310133 404855275 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771812 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1S(=O)(=O)c1cn(C)c(C)n1)NS(C)(=O)=O InChI=1S/C21H38N4O5S2/c1-15(2)17-8-10-18(11-9-17)30-14-20-19(23-31(5,26)27)7-6-12-25(20)32(28,29)21-13-24(4)16(3)22-21/h13,15,17-20,23H,6-12,14H2,1-5H3/t17-,18+,19-,20-/m0/s1 VXNKQYICHAODFO-YRPNKDGESA-N 386117 N-(cis-1-((1,2-dimethyl-1H-imidazol-4- yl)sulfonyl)-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 65::US10508083, Example 65::US11292766, Example 65 Orexin receptor type 2 Homo sapiens 1300 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386117&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310135 404855276 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771813 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1S(=O)(=O)c1cccnc1)NS(C)(=O)=O InChI=1S/C21H35N3O5S2/c1-16(2)17-8-10-18(11-9-17)29-15-21-20(23-30(3,25)26)7-5-13-24(21)31(27,28)19-6-4-12-22-14-19/h4,6,12,14,16-18,20-21,23H,5,7-11,13,15H2,1-3H3/t17-,18+,20-,21-/m0/s1 KQRBLLFHZKZUDN-YHELAOLJSA-N 386118 N-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1- (pyridin-3-ylsulfonyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 66::US10508083, Example 66::US11292766, Example 66 Orexin receptor type 2 Homo sapiens 3800 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386118&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310140 404855277 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771814 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1S(=O)(=O)c1cnn(C)c1)NS(C)(=O)=O InChI=1S/C20H36N4O5S2/c1-15(2)16-7-9-17(10-8-16)29-14-20-19(22-30(4,25)26)6-5-11-24(20)31(27,28)18-12-21-23(3)13-18/h12-13,15-17,19-20,22H,5-11,14H2,1-4H3/t16-,17+,19-,20-/m0/s1 UGFFUHSBYPPPMF-HNJRGHQBSA-N 386119 N-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1-((1- methyl-1H-pyrazol-4- yl)sulfonyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 67::US10508083, Example 67::US11292766, Example 67 Orexin receptor type 2 Homo sapiens 910 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386119&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310136 404855278 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771815 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(C)=O)NS(C)(=O)=O InChI=1S/C18H34N2O4S/c1-13(2)15-7-9-16(10-8-15)24-12-18-17(19-25(4,22)23)6-5-11-20(18)14(3)21/h13,15-19H,5-12H2,1-4H3/t15-,16+,17-,18-/m0/s1 AOMXASJNOXDGQS-MHORFTMASA-N 386120 N-((2R,3S)-1-acetyl-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 103::US10287305, Example 70::US10508083, Example 70::US11292766, Example 103 Orexin receptor type 2 Homo sapiens 97.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386120&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310139 404855279 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771816 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)C1CCCCC1 InChI=1S/C21H38N2O4S/c1-16(24)23-14-6-9-20(22-28(2,25)26)21(23)15-27-19-12-10-18(11-13-19)17-7-4-3-5-8-17/h17-22H,3-15H2,1-2H3/t18-,19+,20-,21-/m0/s1 BCYRFBVDWSSPJS-WOZUAGRISA-N 386121 N-(cis-1-acetyl-2-(((1s,4s)-1,1'- bi(cyclohexyl)-4- yloxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 71::US10508083, Example 71::US11292766, Example 71 Orexin receptor type 2 Homo sapiens 4300 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386121&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310141 404855280 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771817 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)CCO)NS(C)(=O)=O InChI=1S/C19H36N2O5S/c1-14(2)15-6-8-16(9-7-15)26-13-18-17(20-27(3,24)25)5-4-11-21(18)19(23)10-12-22/h14-18,20,22H,4-13H2,1-3H3/t15-,16+,17-,18-/m0/s1 NGHZOQCLAVIFAZ-MHORFTMASA-N 386122 N-(cis-1-(3-hydroxypropanoyl)-2-(((cis- 4-isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 72::US10508083, Example 72::US11292766, Example 72 Orexin receptor type 2 Homo sapiens 89.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386122&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310142 404855281 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771818 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)CC(C)(C)O)NS(C)(=O)=O InChI=1S/C21H40N2O5S/c1-15(2)16-8-10-17(11-9-16)28-14-19-18(22-29(5,26)27)7-6-12-23(19)20(24)13-21(3,4)25/h15-19,22,25H,6-14H2,1-5H3/t16-,17+,18-,19-/m0/s1 IIOVXHYCZRDWPP-RDGPPVDQSA-N 386123 N-(cis-1-(3-hydroxy-3-methylbutanoyl)- 2-(((cis-4- isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 73::US10508083, Example 73::US11292766, Example 73 Orexin receptor type 2 Homo sapiens 560 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386123&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310146 404855282 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771819 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)CCS(C)(=O)=O)NS(C)(=O)=O InChI=1S/C20H38N2O6S2/c1-15(2)16-7-9-17(10-8-16)28-14-19-18(21-30(4,26)27)6-5-12-22(19)20(23)11-13-29(3,24)25/h15-19,21H,5-14H2,1-4H3/t16-,17+,18-,19-/m0/s1 LMGFRQIKBSJZLD-RDGPPVDQSA-N 386125 N-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1-(3- (methylsulfonyl)-propanoyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 74::US10508083, Example 74::US11292766, Example 74 Orexin receptor type 2 Homo sapiens 750 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386125&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310143 404855284 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771820 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)CCC(C)=O)NS(C)(=O)=O InChI=1S/C21H38N2O5S/c1-15(2)17-8-10-18(11-9-17)28-14-20-19(22-29(4,26)27)6-5-13-23(20)21(25)12-7-16(3)24/h15,17-20,22H,5-14H2,1-4H3/t17-,18+,19-,20-/m0/s1 ZTCDUYRCHKTRNR-YRPNKDGESA-N 386127 N-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1-(4- oxopentanoyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 75::US10508083, Example 75::US11292766, Example 75 Orexin receptor type 2 Homo sapiens 220 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386127&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310144 404855286 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771821 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(C)=O)NS(=O)(=O)C(C)C InChI=1S/C20H38N2O4S/c1-14(2)17-8-10-18(11-9-17)26-13-20-19(21-27(24,25)15(3)4)7-6-12-22(20)16(5)23/h14-15,17-21H,6-13H2,1-5H3/t17-,18+,19-,20-/m0/s1 KYMDPDRXJOEXIR-YRPNKDGESA-N 386128 N-(cis-1-acetyl-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)propane-2-sulfonamide::US10287305, Example 76::US10508083, Example 76::US11292766, Example 76 Orexin receptor type 2 Homo sapiens 300 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386128&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310145 404855287 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771822 CCCS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)C(C)C)C(C)=O InChI=1S/C20H38N2O4S/c1-5-13-27(24,25)21-19-7-6-12-22(16(4)23)20(19)14-26-18-10-8-17(9-11-18)15(2)3/h15,17-21H,5-14H2,1-4H3/t17-,18+,19-,20-/m0/s1 PGPHOCNBEFFTNM-YRPNKDGESA-N 386129 N-(cis-1-acetyl-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)propane-1-sulfonamide::US10287305, Example 77::US10508083, Example 77::US11292766, Example 77 Orexin receptor type 2 Homo sapiens 1000 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386129&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310147 404855288 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771823 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(C)=O)NS(=O)(=O)N(C)C InChI=1S/C19H37N3O4S/c1-14(2)16-8-10-17(11-9-16)26-13-19-18(20-27(24,25)21(4)5)7-6-12-22(19)15(3)23/h14,16-20H,6-13H2,1-5H3/t16-,17+,18-,19-/m0/s1 NRIJBKMMFMMNMU-RDGPPVDQSA-N 386130 N'-(cis-1-acetyl-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)-N,N-dimethylsulfuric diamide::US10287305, Example 78::US10508083, Example 78::US11292766, Example 78 Orexin receptor type 2 Homo sapiens 63.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386130&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310148 404855289 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771824 CCNS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)C(C)C)C(C)=O InChI=1S/C19H37N3O4S/c1-5-20-27(24,25)21-18-7-6-12-22(15(4)23)19(18)13-26-17-10-8-16(9-11-17)14(2)3/h14,16-21H,5-13H2,1-4H3/t16-,17+,18-,19-/m0/s1 BUECIRWPTVDSDA-RDGPPVDQSA-N 386132 N-(cis-1-acetyl-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)-N'-ethylsulfuric diamide::US10287305, Example 79::US10508083, Example 79::US11292766, Example 79 Orexin receptor type 2 Homo sapiens 330 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386132&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310149 404855291 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771825 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(C)=O)NS(=O)(=O)C(F)(F)F InChI=1S/C18H31F3N2O4S/c1-12(2)14-6-8-15(9-7-14)27-11-17-16(5-4-10-23(17)13(3)24)22-28(25,26)18(19,20)21/h12,14-17,22H,4-11H2,1-3H3/t14-,15+,16-,17-/m0/s1 AHIZIALKGMAKQC-YVSFHVDLSA-N 386133 N-(cis-1-acetyl-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)-1,1,1- trifluoromethanesulfonamide::US10287305, Example 80::US10508083, Example 80::US11292766, Example 80 Orexin receptor type 2 Homo sapiens 660 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386133&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310150 404855292 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771826 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)COc1ccn(C)n1)NS(C)(=O)=O InChI=1S/C22H38N4O5S/c1-16(2)17-7-9-18(10-8-17)30-14-20-19(24-32(4,28)29)6-5-12-26(20)22(27)15-31-21-11-13-25(3)23-21/h11,13,16-20,24H,5-10,12,14-15H2,1-4H3/t17-,18+,19-,20-/m0/s1 XKQUXJRYSKIYAC-YRPNKDGESA-N 386134 N-((2R,3S)-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1-(((1- methyl-1H-pyrazol-3- yl)oxy)acetyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 84::US10508083, Example 84::US11292766, Example 84 Orexin receptor type 2 Homo sapiens 840 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386134&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310154 404855293 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771827 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)C1CCC(=O)N1)NS(C)(=O)=O InChI=1S/C21H37N3O5S/c1-14(2)15-6-8-16(9-7-15)29-13-19-17(23-30(3,27)28)5-4-12-24(19)21(26)18-10-11-20(25)22-18/h14-19,23H,4-13H2,1-3H3,(H,22,25)/t15-,16+,17-,18?,19-/m0/s1 YPUWKYUYDPXALK-DTRVGAPLSA-N 386135 N-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1-(5- oxoprolyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 87::US10508083, Example 87::US11292766, Example 87 Orexin receptor type 2 Homo sapiens 4900 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386135&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310157 404855294 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771828 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)C1CN(C1)S(C)(=O)=O)NS(C)(=O)=O InChI=1S/C21H39N3O6S2/c1-15(2)16-7-9-18(10-8-16)30-14-20-19(22-31(3,26)27)6-5-11-24(20)21(25)17-12-23(13-17)32(4,28)29/h15-20,22H,5-14H2,1-4H3/t16-,18+,19-,20-/m0/s1 QBNZQHMBKUSPGQ-RNQOJCNYSA-N 386136 N-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1-((1- (methylsulfonyl)azetidin-3- yl)carbonyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 90::US10508083, Example 90::US11292766, Example 90 Orexin receptor type 2 Homo sapiens 2800 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386136&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310160 404855295 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771829 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)C1CC(=O)C1)NS(C)(=O)=O InChI=1S/C21H36N2O5S/c1-14(2)15-6-8-18(9-7-15)28-13-20-19(22-29(3,26)27)5-4-10-23(20)21(25)16-11-17(24)12-16/h14-16,18-20,22H,4-13H2,1-3H3/t15-,18+,19-,20-/m0/s1 CNHUOAAIQKDLGA-LDTOTXGLSA-N 386137 N-((2R,3S)-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1-((3- oxocyclobutyl)carbonyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 91::US10508083, Example 91::US11292766, Example 91 Orexin receptor type 2 Homo sapiens 39.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386137&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310161 404855296 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771830 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)C1CC(O)C1)NS(C)(=O)=O InChI=1S/C21H38N2O5S/c1-14(2)15-6-8-18(9-7-15)28-13-20-19(22-29(3,26)27)5-4-10-23(20)21(25)16-11-17(24)12-16/h14-20,22,24H,4-13H2,1-3H3/t15-,16?,17?,18+,19-,20-/m0/s1 OHGTYQCUKBNUGB-PVFWFNBXSA-N 386139 N-((2R,3S)-1-((3- hydroxycyclobutyl)carbonyl)-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfona::US10287305, Example 92::US10508083, Example 92::US11292766, Example 92 Orexin receptor type 2 Homo sapiens 370 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386139&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310163 404855298 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771831 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)Cn1cnccc1=O)NS(C)(=O)=O InChI=1S/C22H36N4O5S/c1-16(2)17-6-8-18(9-7-17)31-14-20-19(24-32(3,29)30)5-4-12-26(20)22(28)13-25-15-23-11-10-21(25)27/h10-11,15-20,24H,4-9,12-14H2,1-3H3/t17-,18+,19-,20-/m0/s1 BCSWZGZPSFYJMG-YRPNKDGESA-N 386140 N-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1-((6- oxopyrimidin-1(6H)-yl)acetyl)piperidin- 3-yl)methanesulfonamide::US10287305, Example 93::US10508083, Example 93 Orexin receptor type 2 Homo sapiens 2300 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386140&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310164 404855299 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771832 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)C(C)(C)F InChI=1S/C18H33FN2O4S/c1-13(22)21-11-5-6-16(20-26(4,23)24)17(21)12-25-15-9-7-14(8-10-15)18(2,3)19/h14-17,20H,5-12H2,1-4H3/t14-,15+,16-,17-/m0/s1 SXVZLALTRXSAQC-YVSFHVDLSA-N 386141 N-(cis-1-acetyl-2-(((cis-4-(2- fluoropropan-2- yl)cyclohexyl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 95::US10508083, Example 95::US11292766, Example 95 Orexin receptor type 2 Homo sapiens 4300 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386141&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310165 404855300 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771833 COCCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)C(C)C InChI=1S/C20H39N3O5S/c1-15(2)16-7-9-17(10-8-16)28-14-19-18(22-29(4,25)26)6-5-12-23(19)20(24)21-11-13-27-3/h15-19,22H,5-14H2,1-4H3,(H,21,24)/t16-,17+,18-,19-/m0/s1 SUQXQHOFISCNCM-RDGPPVDQSA-N 386142 US10287305, Example 96::US10508083, Example 96::US11292766, Example 96::cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-N-(2- methoxyethyl)-3- ((methylsulfonyl)amino)piperidine-1- carboxamide Orexin receptor type 2 Homo sapiens 26.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386142&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310166 404855301 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771834 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)NCCO)NS(C)(=O)=O InChI=1S/C19H37N3O5S/c1-14(2)15-6-8-16(9-7-15)27-13-18-17(21-28(3,25)26)5-4-11-22(18)19(24)20-10-12-23/h14-18,21,23H,4-13H2,1-3H3,(H,20,24)/t15-,16+,17-,18-/m0/s1 ZFPAGNUYRXXURI-MHORFTMASA-N 386143 US10287305, Example 97::US10508083, Example 97::US11292766, Example 97::cis-N-(2-hydroxyethyl)-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine-1- carboxamide Orexin receptor type 2 Homo sapiens 4.50 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386143&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310168 404855302 C04080 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771835 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)NCC(F)(F)F)NS(C)(=O)=O InChI=1S/C19H34F3N3O4S/c1-13(2)14-6-8-15(9-7-14)29-11-17-16(24-30(3,27)28)5-4-10-25(17)18(26)23-12-19(20,21)22/h13-17,24H,4-12H2,1-3H3,(H,23,26)/t14-,15+,16-,17-/m0/s1 VYDIELLBAIYYLN-YVSFHVDLSA-N 386145 US10287305, Example 98::US10508083, Example 98::US11292766, Example 98::cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)-N-(2,2,2- trifluoroethyl)piperidine-1-carboxamide Orexin receptor type 2 Homo sapiens 2.90 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386145&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310167 404855304 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771836 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)NC1CC1)NS(C)(=O)=O InChI=1S/C20H37N3O4S/c1-14(2)15-6-10-17(11-7-15)27-13-19-18(22-28(3,25)26)5-4-12-23(19)20(24)21-16-8-9-16/h14-19,22H,4-13H2,1-3H3,(H,21,24)/t15-,17+,18-,19-/m0/s1 SYMLSIDNJOTLRU-NQYYFHDYSA-N 386146 US10287305, Example 99::US10508083, Example 99::US11292766, Example 99::cis-N-cyclopropyl-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine-1- carboxamide Orexin receptor type 2 Homo sapiens 13.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386146&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310170 404855305 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771837 CCCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)C(C)C InChI=1S/C20H39N3O4S/c1-5-12-21-20(24)23-13-6-7-18(22-28(4,25)26)19(23)14-27-17-10-8-16(9-11-17)15(2)3/h15-19,22H,5-14H2,1-4H3,(H,21,24)/t16-,17+,18-,19-/m0/s1 FKLCVQLKHNAGTR-RDGPPVDQSA-N 386147 US10287305, Example 100::US10508083, Example 100::US11292766, Example 100::cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)-N- propylpiperidine-1-carboxamide Orexin receptor type 2 Homo sapiens 2.20 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386147&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310169 404855306 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771838 CC(C)NC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)C(C)C InChI=1S/C20H39N3O4S/c1-14(2)16-8-10-17(11-9-16)27-13-19-18(22-28(5,25)26)7-6-12-23(19)20(24)21-15(3)4/h14-19,22H,6-13H2,1-5H3,(H,21,24)/t16-,17+,18-,19-/m0/s1 YLSPJZHAMYRIBN-RDGPPVDQSA-N 386148 US10287305, Example 101::US10508083, Example 101::US11292766, Example 101::cis-N-isopropyl-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine-1- carboxamide Orexin receptor type 2 Homo sapiens 2.30 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386148&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310174 404855307 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771839 CNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)C(C)C InChI=1S/C18H35N3O4S/c1-13(2)14-7-9-15(10-8-14)25-12-17-16(20-26(4,23)24)6-5-11-21(17)18(22)19-3/h13-17,20H,5-12H2,1-4H3,(H,19,22)/t14-,15+,16-,17-/m0/s1 AROAGUIALGVQKV-YVSFHVDLSA-N 386149 (2R,3S)-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-N- methyl-3- ((methylsulfonyl)amino)piperidine-1- carboxamide::US10287305, Example 102::US10508083, Example 102::US11292766, Example 102 Orexin receptor type 2 Homo sapiens 1.20 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386149&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310171 404855308 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771840 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(C)=O)NS(C)(=O)=O InChI=1S/C18H34N2O4S/c1-13(2)15-7-9-16(10-8-15)24-12-18-17(19-25(4,22)23)6-5-11-20(18)14(3)21/h13,15-19H,5-12H2,1-4H3/t15-,16+,17-,18-/m0/s1 AOMXASJNOXDGQS-MHORFTMASA-N 386120 N-((2R,3S)-1-acetyl-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 103::US10287305, Example 70::US10508083, Example 70::US11292766, Example 103 Orexin receptor type 2 Homo sapiens 170 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386120&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310139 404855279 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771841 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)C(C)C InChI=1S/C19H37N3O4S/c1-5-20-19(23)22-12-6-7-17(21-27(4,24)25)18(22)13-26-16-10-8-15(9-11-16)14(2)3/h14-18,21H,5-13H2,1-4H3,(H,20,23)/t15-,16+,17-,18-/m0/s1 QVBNNVDWURLGGQ-MHORFTMASA-N 386064 (2R,3S)-N-ethyl-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxamide::US10287305, Example 104::US10287305, Example 2::US10508083, Example 104::US11292766, Example 104 Orexin receptor type 2 Homo sapiens 2.20 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386064 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386064&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312469 404855223 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771842 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)C(F)(F)F InChI=1S/C16H27F3N2O4S/c1-11(22)21-9-3-4-14(20-26(2,23)24)15(21)10-25-13-7-5-12(6-8-13)16(17,18)19/h12-15,20H,3-10H2,1-2H3/t12-,13+,14-,15-/m0/s1 NADMMIBRVIEWOT-XGUBFFRZSA-N 386152 N-(cis-1-acetyl-2-(((cis-4- (trifluoromethyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 106::US10508083, Example 106::US11292766, Example 106 Orexin receptor type 2 Homo sapiens 4800 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386152&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310175 404855309 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771843 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)C(F)(F)F InChI=1S/C17H30F3N3O4S/c1-3-21-16(24)23-10-4-5-14(22-28(2,25)26)15(23)11-27-13-8-6-12(7-9-13)17(18,19)20/h12-15,22H,3-11H2,1-2H3,(H,21,24)/t12-,13+,14-,15-/m0/s1 YLJJCYKGZRHAQU-XGUBFFRZSA-N 386153 US10287305, Example 107::US10508083, Example 107::US11292766, Example 107::cis-N-ethyl-3-((methylsulfonyl)amino)- 2-(((cis-4- (trifluoromethyl)cyclohexyl)oxy)- methyl)piperidine-1-carboxamide Orexin receptor type 2 Homo sapiens 120 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386153&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310179 404855310 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771844 CN(C)S(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C20H33N3O3S/c1-23(2)27(24,25)22-19-9-6-14-21-20(19)15-26-18-12-10-17(11-13-18)16-7-4-3-5-8-16/h3-5,7-8,17-22H,6,9-15H2,1-2H3/t17-,18+,19-,20-/m0/s1 YFCLIWLIUNZMCZ-YRPNKDGESA-N 386154 N,N-dimethyl-N'-(cis-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)sulfuric diamide::US10287305, Example 109::US10508083, Example 109::US11292766, Example 109 Orexin receptor type 2 Homo sapiens 480 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386154&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310181 404855311 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771845 CN(C)S(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(C)=O InChI=1S/C22H35N3O4S/c1-17(26)25-15-7-10-21(23-30(27,28)24(2)3)22(25)16-29-20-13-11-19(12-14-20)18-8-5-4-6-9-18/h4-6,8-9,19-23H,7,10-16H2,1-3H3/t19-,20+,21-,22-/m0/s1 SDLBPXVIISIXMJ-LRSLUSHPSA-N 386155 N'-(cis-1-acetyl-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)-N,N-dimethylsulfuric diamide::US10287305, Example 111::US10508083, Example 111::US11292766, Example 111 Orexin receptor type 2 Homo sapiens 13.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386155&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310177 404855312 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771846 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccc(F)cc1 InChI=1S/C21H31FN2O4S/c1-15(25)24-13-3-4-20(23-29(2,26)27)21(24)14-28-19-11-7-17(8-12-19)16-5-9-18(22)10-6-16/h5-6,9-10,17,19-21,23H,3-4,7-8,11-14H2,1-2H3/t17-,19+,20-,21-/m0/s1 CPGLETCLXVKBDJ-NRDMVMEKSA-N 386156 N-(cis-1-acetyl-2-(((cis-4-(4- fluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 112::US10508083, Example 112::US11292766, Example 112 Orexin receptor type 2 Homo sapiens 420 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386156&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310178 404855313 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771847 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1C[C@H](C1)c1ccccc1 InChI=1S/C20H31N3O4S/c1-3-21-20(24)23-11-7-10-18(22-28(2,25)26)19(23)14-27-17-12-16(13-17)15-8-5-4-6-9-15/h4-6,8-9,16-19,22H,3,7,10-14H2,1-2H3,(H,21,24)/t16-,17+,18-,19-/m0/s1 DODIMYOCWULPBE-RDGPPVDQSA-N 386157 US10287305, Example 113::US10508083, Example 113::US11292766, Example 113::cis-N-ethyl-3-((methylsulfonyl)amino)- 2-(((cis-3- phenylcyclobutyl)oxy)methyl)- piperidine-1-carboxamide Orexin receptor type 2 Homo sapiens 59.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386157&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310182 404855314 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771848 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1C[C@H](C1)c1ccccc1 InChI=1S/C19H28N2O4S/c1-14(22)21-10-6-9-18(20-26(2,23)24)19(21)13-25-17-11-16(12-17)15-7-4-3-5-8-15/h3-5,7-8,16-20H,6,9-13H2,1-2H3/t16-,17+,18-,19-/m0/s1 RNHMRWOREOILHW-RDGPPVDQSA-N 386158 N-(cis-1-acetyl-2-(((cis-3- phenylcyclobutyl)oxy)methyl)-piperidin- 3-yl)methanesulfonamidea::US10287305, Example 114::US10508083, Example 114::US11292766, Example 114 Orexin receptor type 2 Homo sapiens 3500 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386158&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310183 404855315 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771849 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1F InChI=1S/C19H29FN2O3S/c1-26(23,24)22-18-7-4-12-21-19(18)13-25-15-10-8-14(9-11-15)16-5-2-3-6-17(16)20/h2-3,5-6,14-15,18-19,21-22H,4,7-13H2,1H3/t14-,15+,18-,19-/m0/s1 XOIBZMCBTBRPAQ-QXGSTGNESA-N 386160 N-(cis-2-(((cis-4-(2- fluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 115::US10508083, Example 260::US11292766, Example 260 Orexin receptor type 2 Homo sapiens 770 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386160&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310186 404855317 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771850 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1F InChI=1S/C22H34FN3O4S/c1-3-24-22(27)26-14-6-9-20(25-31(2,28)29)21(26)15-30-17-12-10-16(11-13-17)18-7-4-5-8-19(18)23/h4-5,7-8,16-17,20-21,25H,3,6,9-15H2,1-2H3,(H,24,27)/t16-,17+,20-,21-/m0/s1 FBPIOTYCKPSWSK-JWWGGVBKSA-N 386162 US10287305, Example 117::US10508083, Example 117::US11292766, Example 117::cis-N-ethyl-2-(((cis-4-(2- fluorophenyl)cyclohexyl)oxy)-methyl)- 3-((methylsulfonyl)amino)piperidine-1- carboxamide Orexin receptor type 2 Homo sapiens 0.120 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386162&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310188 404855319 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771851 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ncccn1 InChI=1S/C20H33N5O4S/c1-3-21-20(26)25-13-4-6-17(24-30(2,27)28)18(25)14-29-16-9-7-15(8-10-16)19-22-11-5-12-23-19/h5,11-12,15-18,24H,3-4,6-10,13-14H2,1-2H3,(H,21,26)/t15-,16+,17-,18-/m0/s1 QOFQUYNHZCCTHH-MHORFTMASA-N 386163 US10287305, Example 118::cis-N-ethyl-3-((methylsulfonyl)amino)- 2-(((1-(pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidine-1-carboxamide Orexin receptor type 2 Homo sapiens 4.60 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386163&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310184 404855320 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771852 COCC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C22H34N2O5S/c1-28-16-22(25)24-14-6-9-20(23-30(2,26)27)21(24)15-29-19-12-10-18(11-13-19)17-7-4-3-5-8-17/h3-5,7-8,18-21,23H,6,9-16H2,1-2H3/t18-,19+,20-,21-/m0/s1 UGHMRABTKDKDJW-WOZUAGRISA-N 386164 N-(cis-1-(methoxyacetyl)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 119::US10508083, Example 119::US11292766, Example 119 Orexin receptor type 2 Homo sapiens 30.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386164&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310185 404855321 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771853 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)C1COC1 InChI=1S/C23H34N2O5S/c1-31(27,28)24-21-8-5-13-25(23(26)19-14-29-15-19)22(21)16-30-20-11-9-18(10-12-20)17-6-3-2-4-7-17/h2-4,6-7,18-22,24H,5,8-16H2,1H3/t18-,20+,21-,22-/m0/s1 LRGIOORXBLDLMA-FKVLARQCSA-N 386165 N-(cis-1-(oxetan-3-ylcarbonyl)-2-(((cis- 4-phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 120::US10508083, Example 120::US11292766, Example 120 Orexin receptor type 2 Homo sapiens 61.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386165&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310189 404855322 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771854 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)C1CCOCC1 InChI=1S/C25H38N2O5S/c1-33(29,30)26-23-8-5-15-27(25(28)21-13-16-31-17-14-21)24(23)18-32-22-11-9-20(10-12-22)19-6-3-2-4-7-19/h2-4,6-7,20-24,26H,5,8-18H2,1H3/t20-,22+,23-,24-/m0/s1 MIKDPDSKLVVTQD-IGABQKFOSA-N 386166 N-(cis-2-(((cis-4- phenylcyclohexyl)oxy)methyl)-1- (tetrahydro-2H-pyran-4- ylcarbonyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 121::US10508083, Example 121::US11292766, Example 121 Orexin receptor type 2 Homo sapiens 8.80 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386166&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310190 404855323 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771855 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1ccccc1 InChI=1S/C21H34N4O4S/c1-3-22-21(26)25-13-7-10-19(23-30(2,27)28)20(25)16-29-18-11-14-24(15-12-18)17-8-5-4-6-9-17/h4-6,8-9,18-20,23H,3,7,10-16H2,1-2H3,(H,22,26)/t19-,20-/m0/s1 SSJDAEACPOGEDP-PMACEKPBSA-N 386168 US10287305, Example 123::US10508083, Example 123::US11292766, Example 123::cis-N-ethyl-3-((methylsulfonyl)amino)- 2-(((1-phenylpiperidin-4- yl)oxy)methyl)piperidine-1-carboxamide Orexin receptor type 2 Homo sapiens 390 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386168&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310191 404855325 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771856 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCC(CC1)OC InChI=1S/C17H33N3O5S/c1-4-18-17(21)20-11-5-6-15(19-26(3,22)23)16(20)12-25-14-9-7-13(24-2)8-10-14/h13-16,19H,4-12H2,1-3H3,(H,18,21)/t13?,14?,15-,16-/m0/s1 GMXBDPYWNHUGTK-CKUJCDMFSA-N 386169 US10287305, Example 126::US10508083, Example 126::US11292766, Example 126::cis-N-ethyl-2-(((4- methoxycyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine-1- carboxamide Orexin receptor type 2 Homo sapiens 2600 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386169&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310195 404855326 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771857 C[C@H]1CC[C@H](CC1)OC[C@H]1[C@H](CCCN1C(C)=O)NS(C)(=O)=O InChI=1S/C16H30N2O4S/c1-12-6-8-14(9-7-12)22-11-16-15(17-23(3,20)21)5-4-10-18(16)13(2)19/h12,14-17H,4-11H2,1-3H3/t12-,14+,15-,16-/m0/s1 IABNEMZFAGHVLK-UKMLZYKCSA-N 386170 N-(cis-1-acetyl-2-(((cis-4- methylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 128::US10508083, Example 128::US11292766, Example 128 Orexin receptor type 2 Homo sapiens 2400 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386170&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310197 404855327 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771858 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@@H]1CC[C@H](C)CC1 InChI=1S/C17H33N3O4S/c1-4-18-17(21)20-11-5-6-15(19-25(3,22)23)16(20)12-24-14-9-7-13(2)8-10-14/h13-16,19H,4-12H2,1-3H3,(H,18,21)/t13-,14+,15-,16-/m0/s1 XSPWIVZGGKRSHC-FZKCQIBNSA-N 386171 US10287305, Example 129::US10508083, Example 129::US11292766, Example 129::cis-N-ethyl-2-(((cis-4- methylcyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine-1- carboxamide Orexin receptor type 2 Homo sapiens 39.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386171&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310198 404855328 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771859 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1C[C@@H](C1)c1ccccc1 InChI=1S/C20H31N3O4S/c1-3-21-20(24)23-11-7-10-18(22-28(2,25)26)19(23)14-27-17-12-16(13-17)15-8-5-4-6-9-15/h4-6,8-9,16-19,22H,3,7,10-14H2,1-2H3,(H,21,24)/t16-,17-,18-,19-/m0/s1 DODIMYOCWULPBE-VJANTYMQSA-N 386172 US10287305, Example 130::US10508083, Example 130::US11292766, Example 130::cis-N-ethyl-3-((methylsulfonyl)amino)- 2-(((trans-3- phenylcyclobutyl)oxy)methyl)- piperidine-1-carboxamide Orexin receptor type 2 Homo sapiens 460 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386172&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310182 404855329 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771860 CN(C)CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C23H37N3O4S/c1-25(2)16-23(27)26-15-7-10-21(24-31(3,28)29)22(26)17-30-20-13-11-19(12-14-20)18-8-5-4-6-9-18/h4-6,8-9,19-22,24H,7,10-17H2,1-3H3/t19-,20+,21-,22-/m0/s1 MSYCBOFMQIYTNH-LRSLUSHPSA-N 386173 N-(cis-1-(N,N-dimethylglycyl)-2- (((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 133::US10508083, Example 133::US11292766, Example 133 Orexin receptor type 2 Homo sapiens 1000 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386173&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310199 404855330 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771861 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(F)c1F InChI=1S/C22H33F2N3O4S/c1-3-25-22(28)27-13-5-8-19(26-32(2,29)30)20(27)14-31-16-11-9-15(10-12-16)17-6-4-7-18(23)21(17)24/h4,6-7,15-16,19-20,26H,3,5,8-14H2,1-2H3,(H,25,28)/t15-,16+,19-,20-/m0/s1 QSUQYQFFTPNFFC-JSJNYSNDSA-N 386174 US10287305, Example 136::US10508083, Example 136::US11292766, Example 136::cis-2-(((cis-4-(2,3- difluorophenyl)cyclohexyl)oxy)- methyl)-N-ethyl-3- ((methylsulfonyl)amino)piperidine- 1-carboxamide Orexin receptor type 2 Homo sapiens 0.220 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386174&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312594 404855331 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771862 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cnn(C)c1 InChI=1S/C20H35N5O4S/c1-4-21-20(26)25-11-5-6-18(23-30(3,27)28)19(25)14-29-17-9-7-15(8-10-17)16-12-22-24(2)13-16/h12-13,15,17-19,23H,4-11,14H2,1-3H3,(H,21,26)/t15-,17+,18-,19-/m0/s1 IWGJJEYHVHCZQT-NQYYFHDYSA-N 386175 US10287305, Example 137::US10508083, Example 137::US11292766, Example 137::cis-N-ethyl-2-(((cis-4-(1-methyl- 1H-pyrazol-4- yl)cyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxamide Orexin receptor type 2 Homo sapiens 240 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386175&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312544 404855332 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771863 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)Cn1cccn1 InChI=1S/C24H34N4O4S/c1-33(30,31)26-22-9-5-16-28(24(29)17-27-15-6-14-25-27)23(22)18-32-21-12-10-20(11-13-21)19-7-3-2-4-8-19/h2-4,6-8,14-15,20-23,26H,5,9-13,16-18H2,1H3/t20-,21+,22-,23-/m0/s1 WKQJDZCBXGKWIL-BJESRGMDSA-N 386176 N-(cis-2-(((cis-4- phenylcyclohexyl)oxy)methyl)-1-(1H- pyrazol-1-ylacetyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 138::US10508083, Example 138::US11292766, Example 138 Orexin receptor type 2 Homo sapiens 22.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386176&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310203 404855333 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771864 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)C(F)F InChI=1S/C21H30F2N2O4S/c1-30(27,28)24-18-8-5-13-25(21(26)20(22)23)19(18)14-29-17-11-9-16(10-12-17)15-6-3-2-4-7-15/h2-4,6-7,16-20,24H,5,8-14H2,1H3/t16-,17+,18-,19-/m0/s1 KIALYBQJSMJTAL-RDGPPVDQSA-N 386177 N-(cis-1-(difluoroacetyl)-2-(((cis- 4-phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 139::US10508083, Example 139::US11292766, Example 139 Orexin receptor type 2 Homo sapiens 31.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386177&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310204 404855334 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771865 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CO[C@H](OC1)c1ccccc1 InChI=1S/C20H31N3O6S/c1-3-21-20(24)23-11-7-10-17(22-30(2,25)26)18(23)14-27-16-12-28-19(29-13-16)15-8-5-4-6-9-15/h4-6,8-9,16-19,22H,3,7,10-14H2,1-2H3,(H,21,24)/t16-,17-,18-,19+/m0/s1 SAEFTYLQZISMRU-CADBVGFASA-N 386178 US10287305, Example 140::US10508083, Example 140::cis-N-ethyl-3- ((methylsulfonyl)amino)-2-(((cis-2- phenyl-1,3-dioxan-5- yl)oxy)methyl)piperidine-1- carboxamide Orexin receptor type 2 Homo sapiens 390 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386178&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312477 404855335 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771866 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccc(F)c(F)c1 InChI=1S/C21H30F2N2O4S/c1-14(26)25-11-3-4-20(24-30(2,27)28)21(25)13-29-17-8-5-15(6-9-17)16-7-10-18(22)19(23)12-16/h7,10,12,15,17,20-21,24H,3-6,8-9,11,13H2,1-2H3/t15-,17+,20-,21-/m0/s1 QAKTXKPNOXGFRN-JHOJWFKBSA-N 386179 N-(cis-1-acetyl-2-(((cis-4-(3,4- difluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 141::US10508083, Example 141::US11292766, Example 141 Orexin receptor type 2 Homo sapiens 460 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386179&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310205 404855336 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771867 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1ccc(F)cc1F InChI=1S/C19H28F2N2O3S/c1-27(24,25)23-18-3-2-10-22-19(18)12-26-15-7-4-13(5-8-15)16-9-6-14(20)11-17(16)21/h6,9,11,13,15,18-19,22-23H,2-5,7-8,10,12H2,1H3/t13-,15+,18-,19-/m0/s1 VCQCTWIOLAYTOT-UAFONNFLSA-N 386180 N-(cis-2-(((cis-4-(2,4- difluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 142::US10508083, Example 142::US11292766, Example 142 Orexin receptor type 2 Homo sapiens 4000 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386180&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310206 404855337 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771868 Cn1ccc(n1)[C@@H]1CC[C@@H](CC1)OC[C@@H]1NCCC[C@@H]1NS(C)(=O)=O InChI=1S/C17H30N4O3S/c1-21-11-9-15(19-21)13-5-7-14(8-6-13)24-12-17-16(4-3-10-18-17)20-25(2,22)23/h9,11,13-14,16-18,20H,3-8,10,12H2,1-2H3/t13-,14+,16-,17-/m0/s1 FXBJLWHIBGLHJQ-FSDCSDTHSA-N 386183 N-(cis-2-(((cis-4-(1-methyl-1H- pyrazol-3- yl)cyclohexyl)oxy)methyl)piperidin- 3-yl)methanesulfonamide::US10287305, Example 143::US10508083, Example 143::US11292766, Example 143 Orexin receptor type 2 Homo sapiens 590 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386183&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310207 404855340 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771869 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccc(F)c(F)c1 InChI=1S/C22H33F2N3O4S/c1-3-25-22(28)27-12-4-5-20(26-32(2,29)30)21(27)14-31-17-9-6-15(7-10-17)16-8-11-18(23)19(24)13-16/h8,11,13,15,17,20-21,26H,3-7,9-10,12,14H2,1-2H3,(H,25,28)/t15-,17+,20-,21-/m0/s1 BMQXRQSLTGEMNX-JHOJWFKBSA-N 386184 US10287305, Example 144::US10508083, Example 144::US11292766, Example 144::cis-2-(((cis-4-(3,4- difluorophenyl)cyclohexyl)oxy)- methyl)-N-ethyl-3- ((methylsulfonyl)amino)piperidine- 1-carboxamide Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386184&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312645 404855341 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771870 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccc(F)cc1F InChI=1S/C21H30F2N2O4S/c1-14(26)25-11-3-4-20(24-30(2,27)28)21(25)13-29-17-8-5-15(6-9-17)18-10-7-16(22)12-19(18)23/h7,10,12,15,17,20-21,24H,3-6,8-9,11,13H2,1-2H3/t15-,17+,20-,21-/m0/s1 YLMSKYPKJFAKGP-JHOJWFKBSA-N 386185 N-(cis-1-acetyl-2-(((cis-4-(2,4- difluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 145::US10508083, Example 145::US11292766, Example 145 Orexin receptor type 2 Homo sapiens 810 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386185&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310208 404855342 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771871 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccc(F)cc1F InChI=1S/C22H33F2N3O4S/c1-3-25-22(28)27-12-4-5-20(26-32(2,29)30)21(27)14-31-17-9-6-15(7-10-17)18-11-8-16(23)13-19(18)24/h8,11,13,15,17,20-21,26H,3-7,9-10,12,14H2,1-2H3,(H,25,28)/t15-,17+,20-,21-/m0/s1 UXWZTRYWSBHCKE-JHOJWFKBSA-N 386186 US10287305, Example 146::US10508083, Example 146::US11292766, Example 146::cis-2-(((cis-4-(2,4- difluorophenyl)cyclohexyl)oxy)- methyl)-N-ethyl-3- ((methylsulfonyl)amino)piperidine- 1-carboxamide Orexin receptor type 2 Homo sapiens 2.50 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386186&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312476 404855343 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771872 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(F)c1 InChI=1S/C21H31FN2O4S/c1-15(25)24-12-4-7-20(23-29(2,26)27)21(24)14-28-19-10-8-16(9-11-19)17-5-3-6-18(22)13-17/h3,5-6,13,16,19-21,23H,4,7-12,14H2,1-2H3/t16-,19+,20-,21-/m0/s1 JFWZOOLEKUNFIT-CZGNIMDHSA-N 386187 N-((2R,3S)-1-acetyl-2-(((cis-4-(3- fluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 147::US10508083, Example 147::US11292766, Example 147 Orexin receptor type 2 Homo sapiens 10.00 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386187&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310209 404855344 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771873 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(F)c1 InChI=1S/C22H34FN3O4S/c1-3-24-22(27)26-13-5-8-20(25-31(2,28)29)21(26)15-30-19-11-9-16(10-12-19)17-6-4-7-18(23)14-17/h4,6-7,14,16,19-21,25H,3,5,8-13,15H2,1-2H3,(H,24,27)/t16-,19+,20-,21-/m0/s1 XPBLUJNQFJFGNE-CZGNIMDHSA-N 386188 (2R,3S)-N-ethyl-2-(((cis-4-(3- fluorophenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxamide::US10287305, Example 148::US10508083, Example 148::US11292766, Example 148 Orexin receptor type 2 Homo sapiens 0.053 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386188&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312554 404855345 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771874 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)[C@H]1CCOC1 InChI=1S/C24H36N2O5S/c1-32(28,29)25-22-8-5-14-26(24(27)20-13-15-30-16-20)23(22)17-31-21-11-9-19(10-12-21)18-6-3-2-4-7-18/h2-4,6-7,19-23,25H,5,8-17H2,1H3/t19-,20-,21+,22-,23-/m0/s1 HVGLNIHLBTZQEY-HPAIXVDQSA-N 386189 N-(cis-2-(((cis-4- phenylcyclohexyl)oxy)methyl)-1- ((3S)-tetrahydrofuran-3- ylcarbonyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 149::US10508083, Example 149::US11292766, Example 149 Orexin receptor type 2 Homo sapiens 25.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386189&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310210 404855346 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771875 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)[C@@H]1CCOC1 InChI=1S/C24H36N2O5S/c1-32(28,29)25-22-8-5-14-26(24(27)20-13-15-30-16-20)23(22)17-31-21-11-9-19(10-12-21)18-6-3-2-4-7-18/h2-4,6-7,19-23,25H,5,8-17H2,1H3/t19-,20-,21+,22+,23+/m1/s1 HVGLNIHLBTZQEY-VROINQGHSA-N 386190 N-(cis-2-(((cis-4- phenylcyclohexyl)oxy)methyl)-1- ((3R)-tetrahydrofuran-3- ylcarbonyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 150::US10508083, Example 150::US11292766, Example 150 Orexin receptor type 2 Homo sapiens 30.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386190&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310212 404855347 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771876 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1ncccn1 InChI=1S/C18H29N5O5S/c1-27-18(24)23-10-3-5-15(21-29(2,25)26)16(23)13-28-14-6-11-22(12-7-14)17-19-8-4-9-20-17/h4,8-9,14-16,21H,3,5-7,10-13H2,1-2H3/t15-,16-/m0/s1 QXCKFRHBTUDCEU-HOTGVXAUSA-N 386191 US10287305, Example 151::US10508083, Example 151::US11292766, Example 151::methyl cis-3- ((methylsulfonyl)amino)-2-(((1- (pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidine-1- carboxylate Orexin receptor type 2 Homo sapiens 490 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386191&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310211 404855348 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771877 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)S(C)(=O)=O InChI=1S/C20H32N2O5S2/c1-28(23,24)21-19-9-6-14-22(29(2,25)26)20(19)15-27-18-12-10-17(11-13-18)16-7-4-3-5-8-16/h3-5,7-8,17-21H,6,9-15H2,1-2H3/t17-,18+,19-,20-/m0/s1 DXJQJMSKQZROTF-YRPNKDGESA-N 386192 N-(cis-1-(methylsulfonyl)-2-(((cis- 4-phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 152::US10508083, Example 152::US11292766, Example 152 Orexin receptor type 2 Homo sapiens 290 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386192&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310218 404855349 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771878 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccn(C)n1 InChI=1S/C19H32N4O5S/c1-22-12-10-16(20-22)14-6-8-15(9-7-14)28-13-18-17(21-29(3,25)26)5-4-11-23(18)19(24)27-2/h10,12,14-15,17-18,21H,4-9,11,13H2,1-3H3/t14-,15+,17-,18-/m0/s1 YBAWACNHBIPEOF-MVJTYMMSSA-N 386193 US10287305, Example 154::US10508083, Example 154::US11292766, Example 154::methyl cis-2-(((cis-4-(1-methyl-1H- pyrazol-3- yl)cyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 2400 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386193&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310214 404855350 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771879 CC(C)(C)OC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C24H38N2O5S/c1-24(2,3)31-23(27)26-16-8-11-21(25-32(4,28)29)22(26)17-30-20-14-12-19(13-15-20)18-9-6-5-7-10-18/h5-7,9-10,19-22,25H,8,11-17H2,1-4H3/t19-,20+,21-,22-/m0/s1 YRKGHWKMEPBORS-LRSLUSHPSA-N 386194 US10287305, Example 155::US10508083, Example 155::US11292766, Example 155::tert-butyl cis-3- ((methylsulfonyl)amino)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidine-1-carboxylate Orexin receptor type 2 Homo sapiens 1700 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386194&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310215 404855351 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771880 CN(CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(C)=O InChI=1S/C24H37N3O5S/c1-18(28)26(2)16-24(29)27-15-7-10-22(25-33(3,30)31)23(27)17-32-21-13-11-20(12-14-21)19-8-5-4-6-9-19/h4-6,8-9,20-23,25H,7,10-17H2,1-3H3/t20-,21+,22-,23-/m0/s1 XBGIVGQMVOOCMN-BJESRGMDSA-N 386195 N-methyl-N-(2-(cis-3- ((methylsulfonyl)amino)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-1-yl)-2- oxoethyl)acetamide::US10287305, Example 156::US10508083, Example 156::US11292766, Example 156 Orexin receptor type 2 Homo sapiens 350 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386195&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310219 404855352 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771881 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)Cc1nccs1 InChI=1S/C24H33N3O4S2/c1-33(29,30)26-21-8-5-14-27(24(28)16-23-25-13-15-32-23)22(21)17-31-20-11-9-19(10-12-20)18-6-3-2-4-7-18/h2-4,6-7,13,15,19-22,26H,5,8-12,14,16-17H2,1H3/t19-,20+,21-,22-/m0/s1 MDUDPQVMHAHXIV-LRSLUSHPSA-N 386196 N-(cis-2-(((cis-4- phenylcyclohexyl)oxy)methyl)-1- (1,3-thiazol-2-ylacetyl)piperidin- 3-yl)methanesulfonamide::US10287305, Example 157::US10508083, Example 157::US11292766, Example 157 Orexin receptor type 2 Homo sapiens 140 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386196&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310216 404855353 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771882 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccn(C)n1 InChI=1S/C19H32N4O4S/c1-14(24)23-11-4-5-18(21-28(3,25)26)19(23)13-27-16-8-6-15(7-9-16)17-10-12-22(2)20-17/h10,12,15-16,18-19,21H,4-9,11,13H2,1-3H3/t15-,16+,18-,19-/m0/s1 KPLLJCXLUVAWAQ-NBMJBFSESA-N 386197 N-(cis-1-acetyl-2-(((cis-4-(1- methyl-1H-pyrazol-3- yl)cyclohexyl)oxy)methyl)piperidin- 3-yl)methanesulfonamide::US10287305, Example 158::US10508083, Example 158::US11292766, Example 158 Orexin receptor type 2 Homo sapiens 1600 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386197&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310217 404855354 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771883 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccn(C)n1 InChI=1S/C20H35N5O4S/c1-4-21-20(26)25-12-5-6-18(23-30(3,27)28)19(25)14-29-16-9-7-15(8-10-16)17-11-13-24(2)22-17/h11,13,15-16,18-19,23H,4-10,12,14H2,1-3H3,(H,21,26)/t15-,16+,18-,19-/m0/s1 FYRJKOQOUIHCPX-NBMJBFSESA-N 386200 US10287305, Example 159::US10508083, Example 159::US11292766, Example 159::cis-N-ethyl-2-(((cis-4-(1-methyl- 1H-pyrazol-3- yl)cyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxamide Orexin receptor type 2 Homo sapiens 140 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386200&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312647 404855357 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771884 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1ccccc1C(F)(F)F InChI=1S/C21H30F3N3O5S/c1-31-20(28)27-11-5-7-17(25-33(2,29)30)19(27)14-32-15-9-12-26(13-10-15)18-8-4-3-6-16(18)21(22,23)24/h3-4,6,8,15,17,19,25H,5,7,9-14H2,1-2H3/t17-,19-/m0/s1 SOZNCKAJYMTJTQ-HKUYNNGSSA-N 386201 US10287305, Example 165::US10508083, Example 165::US11292766, Example 165::methyl cis-3- ((methylsulfonyl)amino)-2-(((1-(2- (trifluoromethyl)phenyl)piperidin- 4-yl)oxy)methyl)piperidine-1- carboxylate Orexin receptor type 2 Homo sapiens 3800 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386201&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310225 404855358 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771885 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1ccccc1Cl InChI=1S/C20H30ClN3O5S/c1-28-20(25)24-11-5-7-17(22-30(2,26)27)19(24)14-29-15-9-12-23(13-10-15)18-8-4-3-6-16(18)21/h3-4,6,8,15,17,19,22H,5,7,9-14H2,1-2H3/t17-,19-/m0/s1 OZSTYZLWXCTKHQ-HKUYNNGSSA-N 386202 US10287305, Example 167::US10508083, Example 167::US11292766, Example 167::methyl cis-2-(((1-(2- chlorophenyl)piperidin-4- yl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 2400 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386202&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310227 404855359 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771886 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)C1(O)CC1 InChI=1S/C23H34N2O5S/c1-31(28,29)24-20-8-5-15-25(22(26)23(27)13-14-23)21(20)16-30-19-11-9-18(10-12-19)17-6-3-2-4-7-17/h2-4,6-7,18-21,24,27H,5,8-16H2,1H3/t18-,19+,20-,21-/m0/s1 DBPFAISXQWCVPV-WOZUAGRISA-N 386203 N-(cis-1-((1- hydroxycyclopropyl)carbonyl)-2- (((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 176::US10508083, Example 176::US11292766, Example 176 Orexin receptor type 2 Homo sapiens 45.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386203&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310236 404855360 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771887 CC(=O)C(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C22H32N2O5S/c1-16(25)22(26)24-14-6-9-20(23-30(2,27)28)21(24)15-29-19-12-10-18(11-13-19)17-7-4-3-5-8-17/h3-5,7-8,18-21,23H,6,9-15H2,1-2H3/t18-,19+,20-,21-/m0/s1 JNQZWVLAFNCMQS-WOZUAGRISA-N 386204 N-(cis-2-(((cis-4- phenylcyclohexyl)oxy)methyl)-1- pyruvoylpiperidin-3- yl)methanesulfonamide::US10287305, Example 177::US10508083, Example 177::US11292766, Example 177 Orexin receptor type 2 Homo sapiens 190 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386204&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310237 404855361 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771888 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)NCC#N InChI=1S/C22H32N4O4S/c1-31(28,29)25-20-8-5-15-26(22(27)24-14-13-23)21(20)16-30-19-11-9-18(10-12-19)17-6-3-2-4-7-17/h2-4,6-7,18-21,25H,5,8-12,14-16H2,1H3,(H,24,27)/t18-,19+,20-,21-/m0/s1 OUHMOJLGEQUCEE-WOZUAGRISA-N 386205 US10287305, Example 179::US10508083, Example 179::US11292766, Example 179::cis-N-(cyanomethyl)-3- ((methylsulfonyl)amino)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidine-1-carboxamide Orexin receptor type 2 Homo sapiens 0.310 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386205&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312545 404855362 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771889 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)CC#N InChI=1S/C22H31N3O4S/c1-30(27,28)24-20-8-5-15-25(22(26)13-14-23)21(20)16-29-19-11-9-18(10-12-19)17-6-3-2-4-7-17/h2-4,6-7,18-21,24H,5,8-13,15-16H2,1H3/t18-,19+,20-,21-/m0/s1 RNKYMWWKHUPUKB-WOZUAGRISA-N 386206 N-((2R,3S)-1-(cyanoacetyl)-2- (((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 180::US10508083, Example 180::US11292766, Example 180 Orexin receptor type 2 Homo sapiens 17.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386206&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310240 404855363 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771890 CS(=O)(=O)CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C22H34N2O6S2/c1-31(26,27)16-22(25)24-14-6-9-20(23-32(2,28)29)21(24)15-30-19-12-10-18(11-13-19)17-7-4-3-5-8-17/h3-5,7-8,18-21,23H,6,9-16H2,1-2H3/t18-,19+,20-,21-/m0/s1 QOAOPIQJPNCYCI-WOZUAGRISA-N 386207 N-((2R,3S)-1- ((methylsulfonyl)acetyl)-2-(((cis- 4-phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 181::US10508083, Example 181::US11292766, Example 181 Orexin receptor type 2 Homo sapiens 240 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386207&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310239 404855364 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771891 CCC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C22H34N2O4S/c1-3-22(25)24-15-7-10-20(23-29(2,26)27)21(24)16-28-19-13-11-18(12-14-19)17-8-5-4-6-9-17/h4-6,8-9,18-21,23H,3,7,10-16H2,1-2H3/t18-,19+,20-,21-/m0/s1 UOTZWGSJNUWUJV-WOZUAGRISA-N 386208 N-((2R,3S)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)-1- propionylpiperidin-3- yl)methanesulfonamide::US10287305, Example 182::US10508083, Example 182::US11292766, Example 182 Orexin receptor type 2 Homo sapiens 2.30 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386208&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310241 404855365 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771892 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)[C@H]1CCC(=O)O1 InChI=1S/C24H34N2O6S/c1-33(29,30)25-20-8-5-15-26(24(28)22-13-14-23(27)32-22)21(20)16-31-19-11-9-18(10-12-19)17-6-3-2-4-7-17/h2-4,6-7,18-22,25H,5,8-16H2,1H3/t18-,19+,20-,21-,22+/m0/s1 LURURCBNPRWHKP-LILSUDLASA-N 386209 N-((2R,3S)-1-(((2R)-5- oxotetrahydrofuran-2-yl)carbonyl)- 2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 183::US10508083, Example 183::US11292766, Example 183 Orexin receptor type 2 Homo sapiens 40.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386209&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310242 404855366 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771893 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)[C@@H]1CCC(=O)O1 InChI=1S/C24H34N2O6S/c1-33(29,30)25-20-8-5-15-26(24(28)22-13-14-23(27)32-22)21(20)16-31-19-11-9-18(10-12-19)17-6-3-2-4-7-17/h2-4,6-7,18-22,25H,5,8-16H2,1H3/t18-,19+,20-,21-,22-/m0/s1 LURURCBNPRWHKP-WIYBCGNWSA-N 386210 N-((2R,3S)-1-(((2S)-5- oxotetrahydrofuran-2-yl)carbonyl)- 2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 184::US10508083, Example 184::US11292766, Example 184 Orexin receptor type 2 Homo sapiens 9.30 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386210&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310243 404855367 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771894 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)CO InChI=1S/C21H32N2O5S/c1-29(26,27)22-19-8-5-13-23(21(25)14-24)20(19)15-28-18-11-9-17(10-12-18)16-6-3-2-4-7-16/h2-4,6-7,17-20,22,24H,5,8-15H2,1H3/t17-,18+,19-,20-/m0/s1 UFRJTAZQORBOLY-YRPNKDGESA-N 386211 N-((2R,3S)-1-glycoloyl-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 185::US10508083, Example 185::US11292766, Example 185 Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386211 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386211&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310253 404855368 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771895 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1c(Cl)cccc1Cl InChI=1S/C20H29Cl2N3O5S/c1-29-20(26)25-10-4-7-17(23-31(2,27)28)18(25)13-30-14-8-11-24(12-9-14)19-15(21)5-3-6-16(19)22/h3,5-6,14,17-18,23H,4,7-13H2,1-2H3/t17-,18-/m0/s1 HBJRXGPZCKOXAV-ROUUACIJSA-N 386212 US10287305, Example 186::US10508083, Example 186::US11292766, Example 186::methyl cis-2-(((1-(2,6- dichlorophenyl)piperidin-4- yl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 3300 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386212&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310254 404855369 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771896 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)C1(CC1)C#N InChI=1S/C24H33N3O4S/c1-32(29,30)26-21-8-5-15-27(23(28)24(17-25)13-14-24)22(21)16-31-20-11-9-19(10-12-20)18-6-3-2-4-7-18/h2-4,6-7,19-22,26H,5,8-16H2,1H3/t19-,20+,21-,22-/m0/s1 RZEAHHXYIXEBOX-LRSLUSHPSA-N 386213 N-((2R,3S)-1-((1- cyanocyclopropyl)carbonyl)-2- (((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 187::US10508083, Example 187::US11292766, Example 187 Orexin receptor type 2 Homo sapiens 370 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386213&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310255 404855370 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771897 C[C@H](O)C(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C22H34N2O5S/c1-16(25)22(26)24-14-6-9-20(23-30(2,27)28)21(24)15-29-19-12-10-18(11-13-19)17-7-4-3-5-8-17/h3-5,7-8,16,18-21,23,25H,6,9-15H2,1-2H3/t16-,18-,19+,20-,21-/m0/s1 FNPSNYLEKYTSEJ-RQUKQETFSA-N 386214 N-((2R,3S)-1-((2S)-2- hydroxypropanoyl)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 188::US10508083, Example 188::US11292766, Example 188 Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386214&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310244 404855371 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771898 CC(C)(O)C(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C23H36N2O5S/c1-23(2,27)22(26)25-15-7-10-20(24-31(3,28)29)21(25)16-30-19-13-11-18(12-14-19)17-8-5-4-6-9-17/h4-6,8-9,18-21,24,27H,7,10-16H2,1-3H3/t18-,19+,20-,21-/m0/s1 GAHFOUWLZULQQV-WOZUAGRISA-N 386215 N-(cis-1-(2-hydroxy-2- methylpropanoyl)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 189::US10508083, Example 189::US11292766, Example 189 Orexin receptor type 2 Homo sapiens 78.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386215&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310245 404855372 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771899 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C21H32N2O5S/c1-27-21(24)23-14-6-9-19(22-29(2,25)26)20(23)15-28-18-12-10-17(11-13-18)16-7-4-3-5-8-16/h3-5,7-8,17-20,22H,6,9-15H2,1-2H3/t17-,18+,19-,20-/m0/s1 UXZAJSZFFARTEI-YRPNKDGESA-N 386216 US10287305, Example 191::methyl-d3 (2R,3S)-3- ((methylsulfonyl)amino)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidine-1-carboxylate Orexin receptor type 2 Homo sapiens 2.90 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386216&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search A6F 7SR8,7SQO 130310079 404855373 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771900 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1C[C@H](C1)c1ccc(C)cc1 InChI=1S/C21H33N3O4S/c1-4-22-21(25)24-11-5-6-19(23-29(3,26)27)20(24)14-28-18-12-17(13-18)16-9-7-15(2)8-10-16/h7-10,17-20,23H,4-6,11-14H2,1-3H3,(H,22,25)/t17-,18+,19-,20-/m0/s1 RWTAHMTXMXHXMM-YRPNKDGESA-N 386217 US10287305, Example 192::US10508083, Example 192::US11292766, Example 192::cis-N-ethyl-2-(((cis-3-(4- methylphenyl)cyclobutyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxamide Orexin receptor type 2 Homo sapiens 150 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386217 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386217&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312546 404855374 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771901 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1C[C@H](C1)c1ccccc1)C(=O)C1CC1 InChI=1S/C21H30N2O4S/c1-28(25,26)22-19-8-5-11-23(21(24)16-9-10-16)20(19)14-27-18-12-17(13-18)15-6-3-2-4-7-15/h2-4,6-7,16-20,22H,5,8-14H2,1H3/t17-,18+,19-,20-/m0/s1 SRZDBVVMGMAKOL-YRPNKDGESA-N 386219 N-(cis-1-(cyclopropylcarbonyl)-2- (((cis-3- phenylcyclobutyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 193::US10508083, Example 193::US11292766, Example 193 Orexin receptor type 2 Homo sapiens 300 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386219&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310246 404855376 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771902 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1C[C@H](C1)c1ccccc1 InChI=1S/C19H28N2O5S/c1-25-19(22)21-10-6-9-17(20-27(2,23)24)18(21)13-26-16-11-15(12-16)14-7-4-3-5-8-14/h3-5,7-8,15-18,20H,6,9-13H2,1-2H3/t15-,16+,17-,18-/m0/s1 FFHUCLXXGNGWAV-MHORFTMASA-N 386220 US10287305, Example 194::US10508083, Example 194::US11292766, Example 194::methyl cis-3- ((methylsulfonyl)amino)-2-(((cis-3- phenylcyclobutyl)oxy)methyl)- piperidine-1-carboxylate Orexin receptor type 2 Homo sapiens 2400 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386220&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310248 404855377 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771903 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1ccccc1F InChI=1S/C21H33FN4O4S/c1-3-23-21(27)26-12-6-8-18(24-31(2,28)29)20(26)15-30-16-10-13-25(14-11-16)19-9-5-4-7-17(19)22/h4-5,7,9,16,18,20,24H,3,6,8,10-15H2,1-2H3,(H,23,27)/t18-,20-/m0/s1 JBCDUBKNXQIOJK-ICSRJNTNSA-N 386221 US10287305, Example 195::US10508083, Example 195::US11292766, Example 195::cis-N-ethyl-2-(((1-(2- fluorophenyl)piperidin-4- yl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxamide Orexin receptor type 2 Homo sapiens 250 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386221 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386221&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312482 404855378 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771904 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ncccn1)C(=O)C1CC1 InChI=1S/C20H31N5O4S/c1-30(27,28)23-17-4-2-11-25(19(26)15-5-6-15)18(17)14-29-16-7-12-24(13-8-16)20-21-9-3-10-22-20/h3,9-10,15-18,23H,2,4-8,11-14H2,1H3/t17-,18-/m0/s1 DTFJIRXDIAQFEB-ROUUACIJSA-N 386222 N-(cis-1-(cyclopropylcarbonyl)-2- (((1-(pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 196::US10508083, Example 196::US11292766, Example 196 Orexin receptor type 2 Homo sapiens 30.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386222&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310249 404855379 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771905 C[C@H]1CC[C@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)C1CC1)NS(C)(=O)=O InChI=1S/C18H32N2O4S/c1-13-5-9-15(10-6-13)24-12-17-16(19-25(2,22)23)4-3-11-20(17)18(21)14-7-8-14/h13-17,19H,3-12H2,1-2H3/t13-,15+,16-,17-/m0/s1 PUFBPHNOFHKYHN-ORQFMDKSSA-N 386223 N-(cis-1-(cyclopropylcarbonyl)-2- (((cis-4- methylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 197::US10508083, Example 197::US11292766, Example 197 Orexin receptor type 2 Homo sapiens 100.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386223&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310265 404855380 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771906 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cc(F)ccc1F InChI=1S/C21H30F2N2O4S/c1-14(26)25-11-3-4-20(24-30(2,27)28)21(25)13-29-17-8-5-15(6-9-17)18-12-16(22)7-10-19(18)23/h7,10,12,15,17,20-21,24H,3-6,8-9,11,13H2,1-2H3/t15-,17+,20-,21-/m0/s1 ITANCRFLMXHNQK-JHOJWFKBSA-N 386224 N-(cis-1-acetyl-2-(((cis-4-(2,5- difluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 198::US10508083, Example 217::US11292766, Example 217 Orexin receptor type 2 Homo sapiens 56.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386224&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310267 404855381 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771907 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(F)c1 InChI=1S/C21H31FN2O5S/c1-28-21(25)24-12-4-7-19(23-30(2,26)27)20(24)14-29-18-10-8-15(9-11-18)16-5-3-6-17(22)13-16/h3,5-6,13,15,18-20,23H,4,7-12,14H2,1-2H3/t15-,18+,19-,20-/m0/s1 DOODAOWKCHCXSS-LDTOTXGLSA-N 386225 US10287305, Example 200::US10508083, Example 200::US11292766, Example 200::methyl (2R,3S)-2-(((cis-4-(3- fluorophenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 2.20 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386225 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386225&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310260 404855382 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771908 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ccccc1Cl)C(=O)C1CC1 InChI=1S/C22H32ClN3O4S/c1-31(28,29)24-19-6-4-12-26(22(27)16-8-9-16)21(19)15-30-17-10-13-25(14-11-17)20-7-3-2-5-18(20)23/h2-3,5,7,16-17,19,21,24H,4,6,8-15H2,1H3/t19-,21-/m0/s1 YBAKFEBOYCNLHZ-FPOVZHCZSA-N 386226 N-(cis-2-(((1-(2- chlorophenyl)piperidin-4- yl)oxy)methyl)-1- (cyclopropylcarbonyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 201::US10508083, Example 201::US11292766, Example 201 Orexin receptor type 2 Homo sapiens 2000 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386226&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310250 404855383 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771909 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ncc(F)cn1)C(=O)C1CC1 InChI=1S/C20H30FN5O4S/c1-31(28,29)24-17-3-2-8-26(19(27)14-4-5-14)18(17)13-30-16-6-9-25(10-7-16)20-22-11-15(21)12-23-20/h11-12,14,16-18,24H,2-10,13H2,1H3/t17-,18-/m0/s1 HKCIQYDGWBWBIZ-ROUUACIJSA-N 386227 N-(cis-1-(cyclopropylcarbonyl)-2- (((1-(5-fluoropyrimidin-2- yl)piperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 202::US10508083, Example 202::US11292766, Example 202 Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386227&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310257 404855384 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771910 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(c1)C(F)(F)F InChI=1S/C22H31F3N2O4S/c1-15(28)27-12-4-7-20(26-32(2,29)30)21(27)14-31-19-10-8-16(9-11-19)17-5-3-6-18(13-17)22(23,24)25/h3,5-6,13,16,19-21,26H,4,7-12,14H2,1-2H3/t16-,19+,20-,21-/m0/s1 DTSYXLCOQUYBHZ-CZGNIMDHSA-N 386228 N-(cis-1-acetyl-2-(((cis-4-(3- (trifluoromethyl)phenyl)- cyclohexyl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 204::US10508083, Example 204::US11292766, Example 204 Orexin receptor type 2 Homo sapiens 710 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386228&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310251 404855385 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771911 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(c1)C(F)(F)F InChI=1S/C23H34F3N3O4S/c1-3-27-22(30)29-13-5-8-20(28-34(2,31)32)21(29)15-33-19-11-9-16(10-12-19)17-6-4-7-18(14-17)23(24,25)26/h4,6-7,14,16,19-21,28H,3,5,8-13,15H2,1-2H3,(H,27,30)/t16-,19+,20-,21-/m0/s1 CBVSTHJAEOYNJB-CZGNIMDHSA-N 386229 US10287305, Example 207::US10508083, Example 207::US11292766, Example 207::cis-N-ethyl-3- ((methylsulfonyl)amino)-2-(((cis-4- (3-(trifluoromethyl)phenyl)- cyclohexyl)oxy)methyl)piperidine-1- carboxamide Orexin receptor type 2 Homo sapiens 26.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386229&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312486 404855386 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771912 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ncccn1)C(=O)C1CCCCC1 InChI=1S/C23H37N5O4S/c1-33(30,31)26-20-9-5-14-28(22(29)18-7-3-2-4-8-18)21(20)17-32-19-10-15-27(16-11-19)23-24-12-6-13-25-23/h6,12-13,18-21,26H,2-5,7-11,14-17H2,1H3/t20-,21-/m0/s1 WQEPEHVRALKPIC-SFTDATJTSA-N 386231 N-(cis-1-(cyclohexylcarbonyl)-2- (((1-(pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 208::US10508083, Example 208::US11292766, Example 208 Orexin receptor type 2 Homo sapiens 940 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386231&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310269 404855388 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771913 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1cccc(F)c1Cl)C(=O)C1CC1 InChI=1S/C22H31ClFN3O4S/c1-32(29,30)25-18-5-3-11-27(22(28)15-7-8-15)20(18)14-31-16-9-12-26(13-10-16)19-6-2-4-17(24)21(19)23/h2,4,6,15-16,18,20,25H,3,5,7-14H2,1H3/t18-,20-/m0/s1 ZOTNHDJCWDMYAO-ICSRJNTNSA-N 386232 N-(cis-2-(((1-(2-chloro-3- fluorophenyl)piperidin-4- yl)oxy)methyl)-1- (cyclopropylcarbonyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 209::US10508083, Example 209::US11292766, Example 209 Orexin receptor type 2 Homo sapiens 1900 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386232&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310261 404855389 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771914 CC1(C)CCC(CC1)C(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1ncccn1 InChI=1S/C25H41N5O4S/c1-25(2)11-7-19(8-12-25)23(31)30-15-4-6-21(28-35(3,32)33)22(30)18-34-20-9-16-29(17-10-20)24-26-13-5-14-27-24/h5,13-14,19-22,28H,4,6-12,15-18H2,1-3H3/t21-,22-/m0/s1 WNNVBKZFFHPYEO-VXKWHMMOSA-N 386233 N-(cis-1-((4,4- dimethylcyclohexyl)carbonyl)-2- (((1-(pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 210::US10508083, Example 210::US11292766, Example 210 Orexin receptor type 2 Homo sapiens 3600 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386233&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310264 404855390 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771915 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1(F)F)c1ncccn1)C(=O)C1CC1 InChI=1S/C20H29F2N5O4S/c1-32(29,30)25-15-4-2-10-27(18(28)14-5-6-14)16(15)12-31-17-7-11-26(13-20(17,21)22)19-23-8-3-9-24-19/h3,8-9,14-17,25H,2,4-7,10-13H2,1H3/t15-,16-,17?/m0/s1 UKBVFWTXUNZXOM-PYNWJHIZSA-N 386234 N-(cis-1-(cyclopropylcarbonyl)-2- (((3,3-difluoro-1-(pyrimidin-2- yl)piperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 211::US10508083, Example 211::US11292766, Example 211 Orexin receptor type 2 Homo sapiens 1100 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386234&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310262 404855391 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771916 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1cc(F)ccc1Cl)C(=O)C1CC1 InChI=1S/C22H31ClFN3O4S/c1-32(29,30)25-19-3-2-10-27(22(28)15-4-5-15)21(19)14-31-17-8-11-26(12-9-17)20-13-16(24)6-7-18(20)23/h6-7,13,15,17,19,21,25H,2-5,8-12,14H2,1H3/t19-,21-/m0/s1 NQADBBRTWXJEKY-FPOVZHCZSA-N 386235 N-(cis-2-(((1-(2-chloro-5- fluorophenyl)piperidin-4- yl)oxy)methyl)-1- (cyclopropylcarbonyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 212::US10508083, Example 212::US11292766, Example 212 Orexin receptor type 2 Homo sapiens 2200 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386235&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310266 404855392 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771917 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1c(F)cccc1F)C(=O)C1CC1 InChI=1S/C23H32F2N2O4S/c1-32(29,30)26-20-6-3-13-27(23(28)16-7-8-16)21(20)14-31-17-11-9-15(10-12-17)22-18(24)4-2-5-19(22)25/h2,4-5,15-17,20-21,26H,3,6-14H2,1H3/t15-,17+,20-,21-/m0/s1 GLSLEWCVKVGBHS-JHOJWFKBSA-N 386252 N-((2R,3S)-1-(cyclopropylcarbonyl)- 2-(((cis-4-(2,6- difluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 213::US10508083, Example 213::US11292766, Example 213 Orexin receptor type 2 Homo sapiens 0.440 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386252&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310268 404855409 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771918 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1cc(F)ccc1F)C(=O)C1CC1 InChI=1S/C23H32F2N2O4S/c1-32(29,30)26-21-3-2-12-27(23(28)16-4-5-16)22(21)14-31-18-9-6-15(7-10-18)19-13-17(24)8-11-20(19)25/h8,11,13,15-16,18,21-22,26H,2-7,9-10,12,14H2,1H3/t15-,18+,21-,22-/m0/s1 VDMUPSLZFMRLKX-XSLZUNGDSA-N 386256 N-((2R,3S)-1-(cyclopropylcarbonyl)- 2-(((cis-4-(2,5- difluorophenyl)cyclohexyl)oxy)methyl) piperidin-3-yl)methanesulfonamide::US10287305, Example 214::US10508083, Example 214::US11292766, Example 214 Orexin receptor type 2 Homo sapiens 1.50 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386256&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310271 404855413 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771919 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1c(F)cccc1F InChI=1S/C21H30F2N2O5S/c1-29-21(26)25-12-4-7-18(24-31(2,27)28)19(25)13-30-15-10-8-14(9-11-15)20-16(22)5-3-6-17(20)23/h3,5-6,14-15,18-19,24H,4,7-13H2,1-2H3/t14-,15+,18-,19-/m0/s1 CQYZDBWPHUHEEI-QXGSTGNESA-N 386257 US10287305, Example 215::US10508083, Example 215::US11292766, Example 215::methyl (2R,3S)-2-(((cis-4-(2,6- difluorophenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 2.50 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386257&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310270 404855414 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771920 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCC(F)(CC1)c1cccc(F)c1 InChI=1S/C21H30F2N2O4S/c1-15(26)25-12-4-7-19(24-30(2,27)28)20(25)14-29-18-8-10-21(23,11-9-18)16-5-3-6-17(22)13-16/h3,5-6,13,18-20,24H,4,7-12,14H2,1-2H3/t18?,19-,20-,21?/m0/s1 ZMELDLDBKXDEEN-OMYXNUHHSA-N 386258 N-(cis-1-acetyl-2-(((4-fluoro-4-(3- fluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 216::US10508083, Example 216::US11292766, Example 216 Orexin receptor type 2 Homo sapiens 210 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386258&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310272 404855415 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771921 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cc(F)ccc1F InChI=1S/C21H30F2N2O4S/c1-14(26)25-11-3-4-20(24-30(2,27)28)21(25)13-29-17-8-5-15(6-9-17)18-12-16(22)7-10-19(18)23/h7,10,12,15,17,20-21,24H,3-6,8-9,11,13H2,1-2H3/t15-,17+,20-,21-/m0/s1 ITANCRFLMXHNQK-JHOJWFKBSA-N 386791 N-((2R,3S)-1-acetyl-2-(((cis-4- (2,5- difluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 217 Orexin receptor type 2 Homo sapiens 13.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386791&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310267 404855929 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771922 CCC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1ccccc1F InChI=1S/C21H32FN3O4S/c1-3-21(26)25-12-6-8-18(23-30(2,27)28)20(25)15-29-16-10-13-24(14-11-16)19-9-5-4-7-17(19)22/h4-5,7,9,16,18,20,23H,3,6,8,10-15H2,1-2H3/t18-,20-/m0/s1 FANYAHWBMHJFMT-ICSRJNTNSA-N 386792 N-(cis-2-(((1-(2- fluorophenyl)piperidin-4- yl)oxy)methyl)-1- propionylpiperidin-3- yl)methanesulfonamide::US10287305, Example 219::US10508083, Example 219::US11292766, Example 219 Orexin receptor type 2 Homo sapiens 3000 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386792&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310273 404855930 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771923 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ccccc1F)C(=O)[C@@H]1C[C@@H]1F InChI=1S/C22H31F2N3O4S/c1-32(29,30)25-19-6-4-10-27(22(28)16-13-18(16)24)21(19)14-31-15-8-11-26(12-9-15)20-7-3-2-5-17(20)23/h2-3,5,7,15-16,18-19,21,25H,4,6,8-14H2,1H3/t16-,18+,19+,21+/m1/s1 RZJOCKDDAFARFG-SAJDGTNDSA-N 386793 N-(cis-1-(((1S,2S)-2- fluorocyclopropyl)carbonyl)-2-(((1- (2-fluorophenyl)piperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 221::US10508083, Example 221::US11292766, Example 221 Orexin receptor type 2 Homo sapiens 1600 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386793&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310276 404855931 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771924 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ccccc1F)C(=O)[C@H]1C[C@@H]1F InChI=1S/C22H31F2N3O4S/c1-32(29,30)25-19-6-4-10-27(22(28)16-13-18(16)24)21(19)14-31-15-8-11-26(12-9-15)20-7-3-2-5-17(20)23/h2-3,5,7,15-16,18-19,21,25H,4,6,8-14H2,1H3/t16-,18-,19-,21-/m0/s1 RZJOCKDDAFARFG-WBKMXMRLSA-N 386794 N-(cis-1-(((1R,2S)-2- fluorocyclopropyl)carbonyl)-2-(((1- (2-fluorophenyl)piperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 222::US10508083, Example 222::US11292766, Example 222 Orexin receptor type 2 Homo sapiens 2100 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386794&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310277 404855932 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771925 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ccccc1F)C(=O)C1CCC1 InChI=1S/C23H34FN3O4S/c1-32(29,30)25-20-9-5-13-27(23(28)17-6-4-7-17)22(20)16-31-18-11-14-26(15-12-18)21-10-3-2-8-19(21)24/h2-3,8,10,17-18,20,22,25H,4-7,9,11-16H2,1H3/t20-,22-/m0/s1 JBCSGEQKNPQSFG-UNMCSNQZSA-N 386795 N-(cis-1-(cyclobutylcarbonyl)-2- (((1-(2-fluorophenyl)piperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 223::US10508083, Example 223::US11292766, Example 223 Orexin receptor type 2 Homo sapiens 1100 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386795&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310278 404855933 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771926 CC(C)C(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1ccccc1F InChI=1S/C22H34FN3O4S/c1-16(2)22(27)26-12-6-8-19(24-31(3,28)29)21(26)15-30-17-10-13-25(14-11-17)20-9-5-4-7-18(20)23/h4-5,7,9,16-17,19,21,24H,6,8,10-15H2,1-3H3/t19-,21-/m0/s1 ZZBLCZINLJHZDG-FPOVZHCZSA-N 386796 N-(cis-2-(((1-(2- fluorophenyl)piperidin-4- yl)oxy)methyl)-1- isobutyrylpiperidin-3- yl)methanesulfonamide::US10287305, Example 224::US10508083, Example 224::US11292766, Example 224 Orexin receptor type 2 Homo sapiens 1700 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386796&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310279 404855934 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771927 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ccccc1F)C(=O)C1CC1(F)F InChI=1S/C22H30F3N3O4S/c1-33(30,31)26-18-6-4-10-28(21(29)16-13-22(16,24)25)20(18)14-32-15-8-11-27(12-9-15)19-7-3-2-5-17(19)23/h2-3,5,7,15-16,18,20,26H,4,6,8-14H2,1H3/t16?,18-,20-/m0/s1 VCKOTSRZVWCURX-WNPSOCMYSA-N 386797 N-(cis-1-((2,2- difluorocyclopropyl)carbonyl)-2- (((1-(2-fluorophenyl)piperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 225::US10508083, Example 225::US11292766, Example 225 Orexin receptor type 2 Homo sapiens 1000 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386797&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310280 404855935 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771928 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ccccc1F)C(=O)CC1CC1 InChI=1S/C23H34FN3O4S/c1-32(29,30)25-20-6-4-12-27(23(28)15-17-8-9-17)22(20)16-31-18-10-13-26(14-11-18)21-7-3-2-5-19(21)24/h2-3,5,7,17-18,20,22,25H,4,6,8-16H2,1H3/t20-,22-/m0/s1 OBXFOPFSYXJNPX-UNMCSNQZSA-N 386798 N-(cis-1-(cyclopropylacetyl)-2- (((1-(2-fluorophenyl)piperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 226::US10508083, Example 226::US11292766, Example 226 Orexin receptor type 2 Homo sapiens 2200 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386798&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310282 404855936 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771929 CCCC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1ccccc1F InChI=1S/C22H34FN3O4S/c1-3-7-22(27)26-13-6-9-19(24-31(2,28)29)21(26)16-30-17-11-14-25(15-12-17)20-10-5-4-8-18(20)23/h4-5,8,10,17,19,21,24H,3,6-7,9,11-16H2,1-2H3/t19-,21-/m0/s1 RTHSFHQPGSMFPV-FPOVZHCZSA-N 386799 N-(cis-1-butyryl-2-(((1-(2- fluorophenyl)piperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 227::US10508083, Example 227::US11292766, Example 227 Orexin receptor type 2 Homo sapiens 2400 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386799&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310281 404855937 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771930 CCOC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1ccccc1F InChI=1S/C21H32FN3O5S/c1-3-29-21(26)25-12-6-8-18(23-31(2,27)28)20(25)15-30-16-10-13-24(14-11-16)19-9-5-4-7-17(19)22/h4-5,7,9,16,18,20,23H,3,6,8,10-15H2,1-2H3/t18-,20-/m0/s1 BXIOLPZDHKEYBT-ICSRJNTNSA-N 386800 US10287305, Example 228::US10508083, Example 228::US11292766, Example 228::ethyl cis-2-(((1-(2- fluorophenyl)piperidin-4- yl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 2100 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386800&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310283 404855938 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771931 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ccccc1F)C(=O)C1CCCC1 InChI=1S/C24H36FN3O4S/c1-33(30,31)26-21-10-6-14-28(24(29)18-7-2-3-8-18)23(21)17-32-19-12-15-27(16-13-19)22-11-5-4-9-20(22)25/h4-5,9,11,18-19,21,23,26H,2-3,6-8,10,12-17H2,1H3/t21-,23-/m0/s1 WEYDMPKEVCLLJQ-GMAHTHKFSA-N 386801 N-(cis-1-(cyclopentylcarbonyl)-2- (((1-(2-fluorophenyl)piperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 229::US10508083, Example 229::US11292766, Example 229 Orexin receptor type 2 Homo sapiens 1500 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386801&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310284 404855939 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771932 CC(C)CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1ccccc1F InChI=1S/C23H36FN3O4S/c1-17(2)15-23(28)27-12-6-8-20(25-32(3,29)30)22(27)16-31-18-10-13-26(14-11-18)21-9-5-4-7-19(21)24/h4-5,7,9,17-18,20,22,25H,6,8,10-16H2,1-3H3/t20-,22-/m0/s1 IFVPASJYXYHHBT-UNMCSNQZSA-N 386802 N-(cis-2-(((1-(2- fluorophenyl)piperidin-4- yl)oxy)methyl)-1-(3- methylbutanoyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 230::US10508083, Example 230::US11292766, Example 230 Orexin receptor type 2 Homo sapiens 2600 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386802&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310285 404855940 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771933 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ccccc1F)C(=O)C1CC(=O)C1 InChI=1S/C23H32FN3O5S/c1-33(30,31)25-20-6-4-10-27(23(29)16-13-17(28)14-16)22(20)15-32-18-8-11-26(12-9-18)21-7-3-2-5-19(21)24/h2-3,5,7,16,18,20,22,25H,4,6,8-15H2,1H3/t20-,22-/m0/s1 WXQMIYGTYCOEFY-UNMCSNQZSA-N 386803 N-(cis-2-(((1-(2- fluorophenyl)piperidin-4- yl)oxy)methyl)-1-((3- oxocyclobutyl)carbonyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 233::US10508083, Example 233::US11292766, Example 233 Orexin receptor type 2 Homo sapiens 5000 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386803&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310290 404855941 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771934 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ccccc1F)C(=O)C1CCCCC1 InChI=1S/C25H38FN3O4S/c1-34(31,32)27-22-11-7-15-29(25(30)19-8-3-2-4-9-19)24(22)18-33-20-13-16-28(17-14-20)23-12-6-5-10-21(23)26/h5-6,10,12,19-20,22,24,27H,2-4,7-9,11,13-18H2,1H3/t22-,24-/m0/s1 XQOWQNOMOOLDDW-UPVQGACJSA-N 386804 N-(cis-1-(cyclohexylcarbonyl)-2- (((1-(2-fluorophenyl)piperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 236::US10508083, Example 236::US11292766, Example 236 Orexin receptor type 2 Homo sapiens 1800 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386804&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310291 404855942 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771935 CC(C)OC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1ccccc1F InChI=1S/C22H34FN3O5S/c1-16(2)31-22(27)26-12-6-8-19(24-32(3,28)29)21(26)15-30-17-10-13-25(14-11-17)20-9-5-4-7-18(20)23/h4-5,7,9,16-17,19,21,24H,6,8,10-15H2,1-3H3/t19-,21-/m0/s1 DNMKZFXOZHVXCY-FPOVZHCZSA-N 386805 US10287305, Example 237::US10508083, Example 237::US11292766, Example 237::isopropyl cis-2-(((1-(2- fluorophenyl)piperidin-4- yl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 490 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386805&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310296 404855943 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771936 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ccccc1F)C(=O)C1CCC(F)(F)CC1 InChI=1S/C25H36F3N3O4S/c1-36(33,34)29-21-6-4-14-31(24(32)18-8-12-25(27,28)13-9-18)23(21)17-35-19-10-15-30(16-11-19)22-7-3-2-5-20(22)26/h2-3,5,7,18-19,21,23,29H,4,6,8-17H2,1H3/t21-,23-/m0/s1 IVGZCQROONLQMS-GMAHTHKFSA-N 386806 N-(cis-1-((4,4- difluorocyclohexyl)carbonyl)-2- (((1-(2-fluorophenyl)piperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 238::US10508083, Example 238::US11292766, Example 238 Orexin receptor type 2 Homo sapiens 2100 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386806&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310292 404855944 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771937 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1cc(F)cc(F)c1F InChI=1S/C19H27F3N2O3S/c1-28(25,26)24-17-3-2-8-23-18(17)11-27-14-6-4-12(5-7-14)15-9-13(20)10-16(21)19(15)22/h9-10,12,14,17-18,23-24H,2-8,11H2,1H3/t12-,14+,17-,18-/m0/s1 QGKZBNGSZHARJJ-YENGBRFLSA-N 386807 N-((2R,3S)-2-(((cis-4-(2,3,5- trifluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 239::US10508083, Example 239::US11292766, Example 239 Orexin receptor type 2 Homo sapiens 280 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386807&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310294 404855945 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771938 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1F InChI=1S/C21H31FN2O4S/c1-15(25)24-13-5-8-20(23-29(2,26)27)21(24)14-28-17-11-9-16(10-12-17)18-6-3-4-7-19(18)22/h3-4,6-7,16-17,20-21,23H,5,8-14H2,1-2H3/t16-,17+,20-,21-/m0/s1 JVJULDMOGKFBTE-JWWGGVBKSA-N 386808 N-((2R,3S)-1-acetyl-2-(((cis-4-(2- fluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 240::US10508083, Example 240::US11292766, Example 240 Orexin receptor type 2 Homo sapiens 24.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386808&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310293 404855946 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771939 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cc(F)cc(F)c1 InChI=1S/C21H30F2N2O5S/c1-29-21(26)25-9-3-4-19(24-31(2,27)28)20(25)13-30-18-7-5-14(6-8-18)15-10-16(22)12-17(23)11-15/h10-12,14,18-20,24H,3-9,13H2,1-2H3/t14-,18+,19-,20-/m0/s1 KWKSYSCRIOGBIQ-WBCYEJBOSA-N 386809 US10287305, Example 241::US10508083, Example 241::US11292766, Example 241::methyl (2R,3S)-2-(((cis-4-(3,5- difluorophenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 1.20 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386809&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310295 404855947 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771940 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1cc(F)cc(F)c1)C(=O)C1CC1 InChI=1S/C23H32F2N2O4S/c1-32(29,30)26-21-3-2-10-27(23(28)16-4-5-16)22(21)14-31-20-8-6-15(7-9-20)17-11-18(24)13-19(25)12-17/h11-13,15-16,20-22,26H,2-10,14H2,1H3/t15-,20+,21-,22-/m0/s1 ZUCCGXCBHREFON-NZYDNVMFSA-N 386810 N-((2R,3S)-1-(cyclopropylcarbonyl)- 2-(((cis-4-(3,5- difluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 242::US10508083, Example 242::US11292766, Example 242 Orexin receptor type 2 Homo sapiens 0.880 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386810&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310297 404855948 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771941 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cc(F)cc(F)c1F InChI=1S/C21H29F3N2O4S/c1-13(27)26-9-3-4-19(25-31(2,28)29)20(26)12-30-16-7-5-14(6-8-16)17-10-15(22)11-18(23)21(17)24/h10-11,14,16,19-20,25H,3-9,12H2,1-2H3/t14-,16+,19-,20-/m0/s1 IEIMTYAUSWJDBQ-ZXUOCUECSA-N 386811 N-((2R,3S)-1-acetyl-2-(((cis-4- (2,3,5- trifluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 243::US10508083, Example 243::US11292766, Example 243 Orexin receptor type 2 Homo sapiens 17.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386811 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386811&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310298 404855949 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771942 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cc(F)cc(F)c1F InChI=1S/C21H29F3N2O5S/c1-30-21(27)26-9-3-4-18(25-32(2,28)29)19(26)12-31-15-7-5-13(6-8-15)16-10-14(22)11-17(23)20(16)24/h10-11,13,15,18-19,25H,3-9,12H2,1-2H3/t13-,15+,18-,19-/m0/s1 GCUUWTHDHUNFES-UAFONNFLSA-N 386812 US10287305, Example 244::US10508083, Example 244::US11292766, Example 244::methyl (2R,3S)-3- ((methylsulfonyl)amino)-2-(((cis-4- (2,3,5- trifluorophenyl)cyclohexyl)oxy)- methyl)piperidine-1-carboxylate Orexin receptor type 2 Homo sapiens 2.60 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386812 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386812&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310299 404855950 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771943 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1cc(F)cc(F)c1F)C(=O)C1CC1 InChI=1S/C23H31F3N2O4S/c1-33(30,31)27-20-3-2-10-28(23(29)15-4-5-15)21(20)13-32-17-8-6-14(7-9-17)18-11-16(24)12-19(25)22(18)26/h11-12,14-15,17,20-21,27H,2-10,13H2,1H3/t14-,17+,20-,21-/m0/s1 JKCORIWIYVZNGB-ITNCUTESSA-N 386813 N-((2R,3S)-1-(cyclopropylcarbonyl)- 2-(((cis-4-(2,3,5- trifluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 245::US10508083, Example 245::US11292766, Example 245 Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386813&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310301 404855951 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771944 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ccccc1F)C(=O)C1CC1 InChI=1S/C22H32FN3O4S/c1-31(28,29)24-19-6-4-12-26(22(27)16-8-9-16)21(19)15-30-17-10-13-25(14-11-17)20-7-3-2-5-18(20)23/h2-3,5,7,16-17,19,21,24H,4,6,8-15H2,1H3/t19-,21-/m0/s1 OGXHWNUDSNQYLM-FPOVZHCZSA-N 386814 N-((2R,3S)-1-(cyclopropylcarbonyl)- 2-(((1-(2-fluorophenyl)piperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 246::US10508083, Example 246::US11292766, Example 246 Orexin receptor type 2 Homo sapiens 730 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386814&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310300 404855952 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771945 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ccccc1)C(=O)C1CC1 InChI=1S/C22H33N3O4S/c1-30(27,28)23-20-8-5-13-25(22(26)17-9-10-17)21(20)16-29-19-11-14-24(15-12-19)18-6-3-2-4-7-18/h2-4,6-7,17,19-21,23H,5,8-16H2,1H3/t20-,21-/m0/s1 IUUVVEFANFBZPK-SFTDATJTSA-N 386815 N-(cis-1-(cyclopropylcarbonyl)-2- (((1-phenylpiperidin-4- yl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 247::US10508083, Example 247::US11292766, Example 247 Orexin receptor type 2 Homo sapiens 960 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386815&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310302 404855953 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771946 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1C(F)(F)F InChI=1S/C23H34F3N3O4S/c1-3-27-22(30)29-14-6-9-20(28-34(2,31)32)21(29)15-33-17-12-10-16(11-13-17)18-7-4-5-8-19(18)23(24,25)26/h4-5,7-8,16-17,20-21,28H,3,6,9-15H2,1-2H3,(H,27,30)/t16-,17+,20-,21-/m0/s1 AIRJWVAELPFTGG-JWWGGVBKSA-N 386816 US10287305, Example 249::US10508083, Example 249::US11292766, Example 282::cis-N-ethyl-3- ((methylsulfonyl)amino)-2-(((cis-4- (2-(trifluoromethyl)phenyl)- cyclohexyl)oxy)methyl)piperidine-1- carboxamide Orexin receptor type 2 Homo sapiens 0.610 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386816&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312598 404855954 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771947 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1cccc(F)c1F)C(=O)C1CC1 InChI=1S/C23H32F2N2O4S/c1-32(29,30)26-20-6-3-13-27(23(28)16-7-8-16)21(20)14-31-17-11-9-15(10-12-17)18-4-2-5-19(24)22(18)25/h2,4-5,15-17,20-21,26H,3,6-14H2,1H3/t15-,17+,20-,21-/m0/s1 RJPYOJGEDQQNRA-JHOJWFKBSA-N 386817 N-((2R,3S)-1-(cyclopropylcarbonyl)- 2-(((cis-4-(2,3- difluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 250::US10508083, Example 250::US11292766, Example 250 Orexin receptor type 2 Homo sapiens 1.70 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386817 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386817&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310305 404855955 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771948 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCC(CC1)c1ccccn1)C(=O)C1CC1 InChI=1S/C22H33N3O4S/c1-30(27,28)24-20-6-4-14-25(22(26)17-7-8-17)21(20)15-29-18-11-9-16(10-12-18)19-5-2-3-13-23-19/h2-3,5,13,16-18,20-21,24H,4,6-12,14-15H2,1H3/t16?,18?,20-,21-/m0/s1 DCDIUZLWSPCPJM-NGKMOHNRSA-N 386818 N-(cis-1-(cyclopropylcarbonyl)-2- (((4-(pyridin-2- yl)cyclohexyl)oxy)methyl)piperidin- 3-yl)methanesulfonamide::US10287305, Example 251::US10508083, Example 251::US11292766, Example 251 Orexin receptor type 2 Homo sapiens 240 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386818 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386818&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310304 404855956 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771949 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(c1)C#N InChI=1S/C22H31N3O4S/c1-16(26)25-12-4-7-21(24-30(2,27)28)22(25)15-29-20-10-8-18(9-11-20)19-6-3-5-17(13-19)14-23/h3,5-6,13,18,20-22,24H,4,7-12,15H2,1-2H3/t18-,20+,21-,22-/m0/s1 XHRUTXGGKHJXQU-FKVLARQCSA-N 386819 N-(cis-1-acetyl-2-(((cis-4-(3- cyanophenyl)cyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 252::US10508083, Example 252::US11292766, Example 252 Orexin receptor type 2 Homo sapiens 2900 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386819 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386819&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310303 404855957 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771950 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(c1)C#N InChI=1S/C23H34N4O4S/c1-3-25-23(28)27-13-5-8-21(26-32(2,29)30)22(27)16-31-20-11-9-18(10-12-20)19-7-4-6-17(14-19)15-24/h4,6-7,14,18,20-22,26H,3,5,8-13,16H2,1-2H3,(H,25,28)/t18-,20+,21-,22-/m0/s1 WPIIYWVCJCYHGP-FKVLARQCSA-N 386820 US10287305, Example 254::US10508083, Example 254::US11292766, Example 254::cis-2-(((cis-4-(3- cyanophenyl)cyclohexyl)oxy)methyl)- N-ethyl-3- ((methylsulfonyl)amino)piperidine- 1-carboxamide Orexin receptor type 2 Homo sapiens 88.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386820&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312548 404855958 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771951 CC(C)OC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1ncccn1 InChI=1S/C20H33N5O5S/c1-15(2)30-20(26)25-11-4-6-17(23-31(3,27)28)18(25)14-29-16-7-12-24(13-8-16)19-21-9-5-10-22-19/h5,9-10,15-18,23H,4,6-8,11-14H2,1-3H3/t17-,18-/m0/s1 XLSQMUNQTBWMNI-ROUUACIJSA-N 386821 US10287305, Example 255::US10508083, Example 255::US11292766, Example 255::isopropyl cis-3- ((methylsulfonyl)amino)-2-(((1- (pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidine-1- carboxylate Orexin receptor type 2 Homo sapiens 8.10 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386821&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310307 404855959 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771952 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1c(F)ccc(F)c1F InChI=1S/C21H29F3N2O5S/c1-30-21(27)26-11-3-4-17(25-32(2,28)29)18(26)12-31-14-7-5-13(6-8-14)19-15(22)9-10-16(23)20(19)24/h9-10,13-14,17-18,25H,3-8,11-12H2,1-2H3/t13-,14+,17-,18-/m0/s1 IVBLBXVMHTYNAW-DACLVMHWSA-N 386822 US10287305, Example 257::US10508083, Example 257::US11292766, Example 257::methyl (2R,3S)-3- ((methylsulfonyl)amino)-2-(((cis-4- (2,3,6- trifluorophenyl)cyclohexyl)oxy)- methyl)piperidine-1-carboxylate Orexin receptor type 2 Homo sapiens 2.60 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386822 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386822&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310309 404855960 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771953 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1c(F)ccc(F)c1F)C(=O)C1CC1 InChI=1S/C23H31F3N2O4S/c1-33(30,31)27-19-3-2-12-28(23(29)15-4-5-15)20(19)13-32-16-8-6-14(7-9-16)21-17(24)10-11-18(25)22(21)26/h10-11,14-16,19-20,27H,2-9,12-13H2,1H3/t14-,16+,19-,20-/m0/s1 CSKNLLRCLSVFLI-ZXUOCUECSA-N 386823 N-((2R,3S)-1-(cyclopropylcarbonyl)- 2-(((cis-4-(2,3,6- trifluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 258::US10508083, Example 258::US11292766, Example 258 Orexin receptor type 2 Homo sapiens 0.720 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386823 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386823&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310310 404855961 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771954 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1F InChI=1S/C19H29FN2O3S/c1-26(23,24)22-18-7-4-12-21-19(18)13-25-15-10-8-14(9-11-15)16-5-2-3-6-17(16)20/h2-3,5-6,14-15,18-19,21-22H,4,7-13H2,1H3/t14-,15+,18-,19-/m0/s1 XOIBZMCBTBRPAQ-QXGSTGNESA-N 386824 N-((2R,3S)-2-(((cis-4-(2- fluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 260 Orexin receptor type 2 Homo sapiens 550 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386824&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310186 404855962 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771955 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1C#N InChI=1S/C20H29N3O3S/c1-27(24,25)23-19-7-4-12-22-20(19)14-26-17-10-8-15(9-11-17)18-6-3-2-5-16(18)13-21/h2-3,5-6,15,17,19-20,22-23H,4,7-12,14H2,1H3/t15-,17+,19-,20-/m0/s1 NXYDTYSNNULULH-RKOGWWSCSA-N 386825 N-(cis-2-(((cis-4-(2- cyanophenyl)cyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 262::US10508083, Example 262::US11292766, Example 262 Orexin receptor type 2 Homo sapiens 2500 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386825 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386825&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310313 404855963 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771956 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1C#N InChI=1S/C23H34N4O4S/c1-3-25-23(28)27-14-6-9-21(26-32(2,29)30)22(27)16-31-19-12-10-17(11-13-19)20-8-5-4-7-18(20)15-24/h4-5,7-8,17,19,21-22,26H,3,6,9-14,16H2,1-2H3,(H,25,28)/t17-,19+,21-,22-/m0/s1 BFISSJSHXSPCRK-TZEULACYSA-N 386826 US10287305, Example 263::US10508083, Example 263::US11292766, Example 263::cis-2-(((cis-4-(2- cyanophenyl)cyclohexyl)oxy)methyl)- N-ethyl-3- ((methylsulfonyl)amino)piperidine- 1-carboxamide Orexin receptor type 2 Homo sapiens 57.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386826&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312547 404855964 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771957 CC(C)OC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(F)c1 InChI=1S/C23H35FN2O5S/c1-16(2)31-23(27)26-13-5-8-21(25-32(3,28)29)22(26)15-30-20-11-9-17(10-12-20)18-6-4-7-19(24)14-18/h4,6-7,14,16-17,20-22,25H,5,8-13,15H2,1-3H3/t17-,20+,21-,22-/m0/s1 LAIKWUOHLZYBOB-XGARDCMYSA-N 386827 US10287305, Example 264::US10508083, Example 264::US11292766, Example 264::isopropyl (2R,3S)-2-(((cis-4-(3- fluorophenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386827&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310314 404855965 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771958 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1C#N InChI=1S/C22H31N3O5S/c1-29-22(26)25-13-5-8-20(24-31(2,27)28)21(25)15-30-18-11-9-16(10-12-18)19-7-4-3-6-17(19)14-23/h3-4,6-7,16,18,20-21,24H,5,8-13,15H2,1-2H3/t16-,18+,20-,21-/m0/s1 MJKZKAJOPGHINC-OFCAXSSNSA-N 386828 US10287305, Example 265::US10508083, Example 265::US11292766, Example 265::methyl cis-2-(((cis-4-(2- cyanophenyl)cyclohexyl)oxy)methyl)- 3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 2300 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386828&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310315 404855966 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771959 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@@H]1C[C@H](Cc2ccccc2)C1 InChI=1S/C21H33N3O4S/c1-3-22-21(25)24-11-7-10-19(23-29(2,26)27)20(24)15-28-18-13-17(14-18)12-16-8-5-4-6-9-16/h4-6,8-9,17-20,23H,3,7,10-15H2,1-2H3,(H,22,25)/t17-,18+,19-,20-/m0/s1 GLXBTOQTDADSIE-YRPNKDGESA-N 386829 US10287305, Example 266::US10508083, Example 266::US11292766, Example 266::cis-2-(((cis-3- benzylcyclobutyl)oxy)methyl)-N- ethyl-3- ((methylsulfonyl)amino)piperidine- 1-carboxamide Orexin receptor type 2 Homo sapiens 3700 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386829&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312549 404855967 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771960 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1F InChI=1S/C21H31FN2O5S/c1-28-21(25)24-13-5-8-19(23-30(2,26)27)20(24)14-29-16-11-9-15(10-12-16)17-6-3-4-7-18(17)22/h3-4,6-7,15-16,19-20,23H,5,8-14H2,1-2H3/t15-,16+,19-,20-/m0/s1 KVUOBRGDNORSIO-JSJNYSNDSA-N 386830 US10287305, Example 267::US10508083, Example 267::US11292766, Example 267::methyl (2R,3S)-2-(((cis-4-(2- fluorophenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 3.40 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386830 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386830&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310319 404855968 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771961 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1F)C(=O)C1CC1 InChI=1S/C23H33FN2O4S/c1-31(28,29)25-21-7-4-14-26(23(27)17-8-9-17)22(21)15-30-18-12-10-16(11-13-18)19-5-2-3-6-20(19)24/h2-3,5-6,16-18,21-22,25H,4,7-15H2,1H3/t16-,18+,21-,22-/m0/s1 BKTXDLQNYWMTTG-REIYTJMXSA-N 386831 N-((2R,3S)-1-(cyclopropylcarbonyl)- 2-(((cis-4-(2- fluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 268::US10508083, Example 268::US11292766, Example 268 Orexin receptor type 2 Homo sapiens 1.50 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386831 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386831&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310320 404855969 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771962 COc1cccc(c1)[C@@H]1CC[C@@H](CC1)OC[C@@H]1NCCC[C@@H]1NS(C)(=O)=O InChI=1S/C20H32N2O4S/c1-25-18-6-3-5-16(13-18)15-8-10-17(11-9-15)26-14-20-19(7-4-12-21-20)22-27(2,23)24/h3,5-6,13,15,17,19-22H,4,7-12,14H2,1-2H3/t15-,17+,19-,20-/m0/s1 GIONWKPBUKUQCU-RKOGWWSCSA-N 386832 N-(cis-2-(((cis-4-(3- methoxyphenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 269::US10508083, Example 269::US11292766, Example 269 Orexin receptor type 2 Homo sapiens 3000 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386832 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386832&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310316 404855970 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771963 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(OC)c1 InChI=1S/C22H34N2O6S/c1-28-19-7-4-6-17(14-19)16-9-11-18(12-10-16)30-15-21-20(23-31(3,26)27)8-5-13-24(21)22(25)29-2/h4,6-7,14,16,18,20-21,23H,5,8-13,15H2,1-3H3/t16-,18+,20-,21-/m0/s1 PICSDPDTFKVXHU-OFCAXSSNSA-N 386833 US10287305, Example 270::US10508083, Example 270::US11292766, Example 270::methyl cis-2-(((cis-4-(3- methoxyphenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 80.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386833 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386833&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310317 404855971 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771964 COc1cccc(c1)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(C)=O)NS(C)(=O)=O InChI=1S/C22H34N2O5S/c1-16(25)24-13-5-8-21(23-30(3,26)27)22(24)15-29-19-11-9-17(10-12-19)18-6-4-7-20(14-18)28-2/h4,6-7,14,17,19,21-23H,5,8-13,15H2,1-3H3/t17-,19+,21-,22-/m0/s1 WUPOVEARVDYDIQ-TZEULACYSA-N 386834 N-(cis-1-acetyl-2-(((cis-4-(3- methoxyphenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 271::US10508083, Example 271::US11292766, Example 271 Orexin receptor type 2 Homo sapiens 650 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386834&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310323 404855972 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771965 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1cccc(F)c1)C(=O)OC1CC1 InChI=1S/C23H33FN2O5S/c1-32(28,29)25-21-6-3-13-26(23(27)31-20-11-12-20)22(21)15-30-19-9-7-16(8-10-19)17-4-2-5-18(24)14-17/h2,4-5,14,16,19-22,25H,3,6-13,15H2,1H3/t16-,19+,21-,22-/m0/s1 NEQVRISGAZCBKE-NHRGSCSFSA-N 386835 US10287305, Example 272::US10508083, Example 272::US11292766, Example 272::cyclopropyl (2R,3S)-2-(((cis-4-(3- fluorophenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 28.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386835&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310318 404855973 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771966 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@@]2(CC1)OCc1ccccc21 InChI=1S/C22H32N2O6S/c1-28-21(25)24-13-5-8-19(23-31(2,26)27)20(24)15-29-17-9-11-22(12-10-17)18-7-4-3-6-16(18)14-30-22/h3-4,6-7,17,19-20,23H,5,8-15H2,1-2H3/t17-,19-,20-,22-/m0/s1 NPGRVNHNFNHNED-UTYWTXRGSA-N 386836 US10287305, Example 274::US10508083, Example 274::US11292766, Example 274::methyl cis-3- ((methylsulfonyl)amino)-2- (((1r,4'r)-3H-spiro[2-benzofuran- 1,1'-cyclohexan]-4'- yloxy)methyl)piperidine-1- carboxylate Orexin receptor type 2 Homo sapiens 260 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386836&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310322 404855974 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771967 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@]2(CC1)OCc1ccccc21 InChI=1S/C22H32N2O6S/c1-28-21(25)24-13-5-8-19(23-31(2,26)27)20(24)15-29-17-9-11-22(12-10-17)18-7-4-3-6-16(18)14-30-22/h3-4,6-7,17,19-20,23H,5,8-15H2,1-2H3/t17-,19-,20-,22+/m0/s1 NPGRVNHNFNHNED-WCCBULMPSA-N 386837 US10287305, Example 275::US10508083, Example 275::US11292766, Example 275::methyl cis-3- ((methylsulfonyl)amino)-2- (((1s,4's)-3H-spiro[2-benzofuran- 1,1'-cyclohexan]-4'- yloxy)methyl)piperidine-1- carboxylate Orexin receptor type 2 Homo sapiens 3100 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386837&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310322 404855975 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771968 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1cccc(F)c1)C(=O)OCC(F)(F)F InChI=1S/C22H30F4N2O5S/c1-34(30,31)27-19-6-3-11-28(21(29)33-14-22(24,25)26)20(19)13-32-18-9-7-15(8-10-18)16-4-2-5-17(23)12-16/h2,4-5,12,15,18-20,27H,3,6-11,13-14H2,1H3/t15-,18+,19-,20-/m0/s1 RYWRYCZGFHWMFZ-LDTOTXGLSA-N 386838 2,2,2-trifluoroethyl (2R,3S)-2- (((cis-4-(3- fluorophenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate::US10287305, Example 276::US10508083, Example 276::US11292766, Example 276 Orexin receptor type 2 Homo sapiens 110 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386838 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386838&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310324 404855976 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771969 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1OC InChI=1S/C22H34N2O6S/c1-28-21-9-5-4-7-18(21)16-10-12-17(13-11-16)30-15-20-19(23-31(3,26)27)8-6-14-24(20)22(25)29-2/h4-5,7,9,16-17,19-20,23H,6,8,10-15H2,1-3H3/t16-,17+,19-,20-/m0/s1 LWECPUGTQDMNKQ-HNJRGHQBSA-N 386839 US10287305, Example 277::US10508083, Example 277::US11292766, Example 277::methyl (2R,3S)-2-(((cis-4-(2- methoxyphenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 2.90 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386839&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310325 404855977 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771970 CCS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)C1CC1 InChI=1S/C24H36N2O4S/c1-2-31(28,29)25-22-9-6-16-26(24(27)20-10-11-20)23(22)17-30-21-14-12-19(13-15-21)18-7-4-3-5-8-18/h3-5,7-8,19-23,25H,2,6,9-17H2,1H3/t19-,21+,22-,23-/m0/s1 CDIZBIQDWASGMQ-MALNDZBISA-N 386840 N-(cis-1-(cyclopropylcarbonyl)-2- (((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)ethanesulfonamide::US10287305, Example 279::US10508083, Example 279::US11292766, Example 279 Orexin receptor type 2 Homo sapiens 5.20 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386840&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310327 404855978 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771971 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1C[C@@H](C1)Oc1ccccc1 InChI=1S/C20H31N3O5S/c1-3-21-20(24)23-11-7-10-18(22-29(2,25)26)19(23)14-27-16-12-17(13-16)28-15-8-5-4-6-9-15/h4-6,8-9,16-19,22H,3,7,10-14H2,1-2H3,(H,21,24)/t16-,17-,18-,19-/m0/s1 HLMWGMVFQXZIKR-VJANTYMQSA-N 386841 US10287305, Example 281::US10508083, Example 281::US11292766, Example 281::cis-N-ethyl-3- ((methylsulfonyl)amino)-2-(((trans- 3-phenoxycyclobutyl)oxy)methyl)- piperidine-1-carboxamide Orexin receptor type 2 Homo sapiens 3300 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386841&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312500 404855979 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771972 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1C(F)(F)F InChI=1S/C23H34F3N3O4S/c1-3-27-22(30)29-14-6-9-20(28-34(2,31)32)21(29)15-33-17-12-10-16(11-13-17)18-7-4-5-8-19(18)23(24,25)26/h4-5,7-8,16-17,20-21,28H,3,6,9-15H2,1-2H3,(H,27,30)/t16-,17+,20-,21-/m0/s1 AIRJWVAELPFTGG-JWWGGVBKSA-N 386842 (2R,3S)-N-ethyl-3- ((methylsulfonyl)amino)-2-(((cis-4- (2-(trifluoromethyl)phenyl)- cyclohexyl)oxy)methyl)piperidine-1- carboxamide::US10287305, Example 282 Orexin receptor type 2 Homo sapiens 0.550 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386842&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312598 404855980 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771973 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1C(F)(F)F)C(=O)CO InChI=1S/C22H31F3N2O5S/c1-33(30,31)26-19-7-4-12-27(21(29)13-28)20(19)14-32-16-10-8-15(9-11-16)17-5-2-3-6-18(17)22(23,24)25/h2-3,5-6,15-16,19-20,26,28H,4,7-14H2,1H3/t15-,16+,19-,20-/m0/s1 DICSSPNUTKDXPR-JSJNYSNDSA-N 386843 N-((2R,3S)-1-glycoloyl-2-(((cis-4- (2-(trifluoromethyl)phenyl)- cyclohexyl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 283::US10508083, Example 283::US11292766, Example 283 Orexin receptor type 2 Homo sapiens 8.90 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386843&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310331 404855981 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771974 CC1(CC1)OC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1ncccn1 InChI=1S/C21H33N5O5S/c1-21(8-9-21)31-20(27)26-12-3-5-17(24-32(2,28)29)18(26)15-30-16-6-13-25(14-7-16)19-22-10-4-11-23-19/h4,10-11,16-18,24H,3,5-9,12-15H2,1-2H3/t17-,18-/m0/s1 TXRQRJLDSMMLKT-ROUUACIJSA-N 386844 1-methylcyclopropyl cis-3- ((methylsulfonyl)amino)-2-(((1- (pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidine-1- carboxylate::US10287305, Example 284::US10508083, Example 284::US11292766, Example 284 Orexin receptor type 2 Homo sapiens 260 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386844&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310329 404855982 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771975 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ncccn1)C(=O)OCC(F)(F)F InChI=1S/C19H28F3N5O5S/c1-33(29,30)25-15-4-2-9-27(18(28)32-13-19(20,21)22)16(15)12-31-14-5-10-26(11-6-14)17-23-7-3-8-24-17/h3,7-8,14-16,25H,2,4-6,9-13H2,1H3/t15-,16-/m0/s1 JKZPMOHVVITSLR-HOTGVXAUSA-N 386845 2,2,2-trifluoroethyl cis-3- ((methylsulfonyl)amino)-2-(((1- (pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidine-1- carboxylate::US10287305, Example 286::US10287305, Example 305::US10508083, Example 305::US11292766, Example 305 Orexin receptor type 2 Homo sapiens 130 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386845&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310330 404855983 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771976 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ncccn1)C(=O)OC1CC1 InChI=1S/C20H31N5O5S/c1-31(27,28)23-17-4-2-11-25(20(26)30-16-5-6-16)18(17)14-29-15-7-12-24(13-8-15)19-21-9-3-10-22-19/h3,9-10,15-18,23H,2,4-8,11-14H2,1H3/t17-,18-/m0/s1 VDBYJXPFOPFPRH-ROUUACIJSA-N 386846 US10287305, Example 287::US10508083, Example 287::US11292766, Example 287::cyclopropyl cis-3- ((methylsulfonyl)amino)-2-(((1- (pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidine-1- carboxylate Orexin receptor type 2 Homo sapiens 150 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386846&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310332 404855984 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771977 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ccccc1F)C(=O)OC1CC1 InChI=1S/C22H32FN3O5S/c1-32(28,29)24-19-6-4-12-26(22(27)31-17-8-9-17)21(19)15-30-16-10-13-25(14-11-16)20-7-3-2-5-18(20)23/h2-3,5,7,16-17,19,21,24H,4,6,8-15H2,1H3/t19-,21-/m0/s1 ZQSWYMMAPBTFFO-FPOVZHCZSA-N 386847 US10287305, Example 290::US10508083, Example 290::US11292766, Example 290::cyclopropyl cis-2-(((1-(2- fluorophenyl)piperidin-4- yl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 3300 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386847&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310335 404855985 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771978 COc1ccccc1[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(C)=O)NS(C)(=O)=O InChI=1S/C22H34N2O5S/c1-16(25)24-14-6-8-20(23-30(3,26)27)21(24)15-29-18-12-10-17(11-13-18)19-7-4-5-9-22(19)28-2/h4-5,7,9,17-18,20-21,23H,6,8,10-15H2,1-3H3/t17-,18+,20-,21-/m0/s1 OAOMXVGVNLTKRL-YHELAOLJSA-N 386848 N-((2R,3S)-1-acetyl-2-(((cis-4-(2- methoxyphenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 291::US10508083, Example 291::US11292766, Example 291 Orexin receptor type 2 Homo sapiens 26.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386848&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310336 404855986 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771979 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1OC(F)(F)F InChI=1S/C22H31F3N2O5S/c1-15(28)27-13-5-7-19(26-33(2,29)30)20(27)14-31-17-11-9-16(10-12-17)18-6-3-4-8-21(18)32-22(23,24)25/h3-4,6,8,16-17,19-20,26H,5,7,9-14H2,1-2H3/t16-,17+,19-,20-/m0/s1 FDVPXQUKIYEFGS-HNJRGHQBSA-N 386849 N-(cis-1-acetyl-2-(((cis-4-(2- (trifluoromethoxy)phenyl)- cyclohexyl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 293::US10508083, Example 293::US11292766, Example 293 Orexin receptor type 2 Homo sapiens 540 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386849&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310338 404855987 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771980 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1OC(F)(F)F)C(=O)C1CC1 InChI=1S/C24H33F3N2O5S/c1-35(31,32)28-20-6-4-14-29(23(30)17-8-9-17)21(20)15-33-18-12-10-16(11-13-18)19-5-2-3-7-22(19)34-24(25,26)27/h2-3,5,7,16-18,20-21,28H,4,6,8-15H2,1H3/t16-,18+,20-,21-/m0/s1 FNJWCCBOYGOOOB-OFCAXSSNSA-N 386850 N-(cis-1-(cyclopropylcarbonyl)-2- (((cis-4-(2- (trifluoromethoxy)phenyl)- cyclohexyl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 294::US10508083, Example 294::US11292766, Example 294 Orexin receptor type 2 Homo sapiens 130 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386850&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310339 404855988 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771981 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1OC(F)(F)F InChI=1S/C23H34F3N3O5S/c1-3-27-22(30)29-14-6-8-19(28-35(2,31)32)20(29)15-33-17-12-10-16(11-13-17)18-7-4-5-9-21(18)34-23(24,25)26/h4-5,7,9,16-17,19-20,28H,3,6,8,10-15H2,1-2H3,(H,27,30)/t16-,17+,19-,20-/m0/s1 QSGIODMFDBJOTO-HNJRGHQBSA-N 386851 US10287305, Example 295::US10508083, Example 295::US11292766, Example 295::cis-N-ethyl-3- ((methylsulfonyl)amino)-2-(((cis-4- (2-(trifluoromethoxy)phenyl)- cyclohexyl)oxy)methyl)piperidine-1- carboxamide Orexin receptor type 2 Homo sapiens 4.20 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386851&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312559 404855989 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771982 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(OC(F)(F)F)c1 InChI=1S/C22H31F3N2O5S/c1-15(28)27-12-4-7-20(26-33(2,29)30)21(27)14-31-18-10-8-16(9-11-18)17-5-3-6-19(13-17)32-22(23,24)25/h3,5-6,13,16,18,20-21,26H,4,7-12,14H2,1-2H3/t16-,18+,20-,21-/m0/s1 FDDUTDMOKGLLDT-OFCAXSSNSA-N 386852 N-(cis-1-acetyl-2-(((cis-4-(3- (trifluoromethoxy)phenyl)cyclohexyl) oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 297::US10508083, Example 297::US11292766, Example 297 Orexin receptor type 2 Homo sapiens 2100 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386852&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310340 404855990 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771983 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(OC(F)(F)F)c1 InChI=1S/C22H31F3N2O6S/c1-31-21(28)27-12-4-7-19(26-34(2,29)30)20(27)14-32-17-10-8-15(9-11-17)16-5-3-6-18(13-16)33-22(23,24)25/h3,5-6,13,15,17,19-20,26H,4,7-12,14H2,1-2H3/t15-,17+,19-,20-/m0/s1 FFALFBUYRHALAB-RKOGWWSCSA-N 386853 US10287305, Example 298::US10508083, Example 298::US11292766, Example 298::methyl cis-3- ((methylsulfonyl)amino)-2-(((cis-4- (3-(trifluoromethoxy)phenyl)- cyclohexyl)oxy)methyl)piperidine-1- carboxylate Orexin receptor type 2 Homo sapiens 280 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386853&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310343 404855991 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771984 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1cccc(OC(F)(F)F)c1)C(=O)C1CC1 InChI=1S/C24H33F3N2O5S/c1-35(31,32)28-21-6-3-13-29(23(30)17-7-8-17)22(21)15-33-19-11-9-16(10-12-19)18-4-2-5-20(14-18)34-24(25,26)27/h2,4-5,14,16-17,19,21-22,28H,3,6-13,15H2,1H3/t16-,19+,21-,22-/m0/s1 YEMSPJVUHNHYEM-NHRGSCSFSA-N 386854 N-(cis-1-(cyclopropylcarbonyl)-2- (((cis-4-(3- (trifluoromethoxy)phenyl)- cyclohexyl)oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 299::US10508083, Example 299::US11292766, Example 299 Orexin receptor type 2 Homo sapiens 95.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386854&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310342 404855992 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771985 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(OC(F)(F)F)c1 InChI=1S/C23H34F3N3O5S/c1-3-27-22(30)29-13-5-8-20(28-35(2,31)32)21(29)15-33-18-11-9-16(10-12-18)17-6-4-7-19(14-17)34-23(24,25)26/h4,6-7,14,16,18,20-21,28H,3,5,8-13,15H2,1-2H3,(H,27,30)/t16-,18+,20-,21-/m0/s1 BTOYWYKRBBLMTH-OFCAXSSNSA-N 386855 US10287305, Example 300::US10508083, Example 300::US11292766, Example 300::cis-N-ethyl-3- ((methylsulfonyl)amino)-2-(((cis-4- (3-(trifluoromethoxy)phenyl)- cyclohexyl)oxy)methyl)piperidine-1- carboxamide Orexin receptor type 2 Homo sapiens 9.70 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386855&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312506 404855993 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771986 CCS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)OC InChI=1S/C22H34N2O5S/c1-3-30(26,27)23-20-10-7-15-24(22(25)28-2)21(20)16-29-19-13-11-18(12-14-19)17-8-5-4-6-9-17/h4-6,8-9,18-21,23H,3,7,10-16H2,1-2H3/t18-,19+,20-,21-/m0/s1 HTSFJNJMVOKEJD-WOZUAGRISA-N 386856 US10287305, Example 301::US10508083, Example 301::US11292766, Example 301::methyl cis-3- ((ethylsulfonyl)amino)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidine-1-carboxylate Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386856&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310344 404855994 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771987 CCOC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C22H34N2O5S/c1-3-28-22(25)24-15-7-10-20(23-30(2,26)27)21(24)16-29-19-13-11-18(12-14-19)17-8-5-4-6-9-17/h4-6,8-9,18-21,23H,3,7,10-16H2,1-2H3/t18-,19+,20-,21-/m0/s1 GHZYGSCCYQLHKJ-WOZUAGRISA-N 386857 US10287305, Example 303::US10508083, Example 303::ethyl (2R,3S)-3- ((methylsulfonyl)amino)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidine-1-carboxylate Orexin receptor type 2 Homo sapiens 15.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386857&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310345 404855995 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771988 COc1cccc(c1)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)C1CC1)NS(C)(=O)=O InChI=1S/C24H36N2O5S/c1-30-21-6-3-5-19(15-21)17-10-12-20(13-11-17)31-16-23-22(25-32(2,28)29)7-4-14-26(23)24(27)18-8-9-18/h3,5-6,15,17-18,20,22-23,25H,4,7-14,16H2,1-2H3/t17-,20+,22-,23-/m0/s1 ZKOGOCKVIAAYFI-NOHMWWQBSA-N 386858 N-((2R,3S)-1-(cyclopropylcarbonyl)- 2-(((cis-4-(3- methoxyphenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 304::US10508083, Example 304 Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386858&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310348 404855996 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771989 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ncccn1)C(=O)OCC(F)(F)F InChI=1S/C19H28F3N5O5S/c1-33(29,30)25-15-4-2-9-27(18(28)32-13-19(20,21)22)16(15)12-31-14-5-10-26(11-6-14)17-23-7-3-8-24-17/h3,7-8,14-16,25H,2,4-6,9-13H2,1H3/t15-,16-/m0/s1 JKZPMOHVVITSLR-HOTGVXAUSA-N 386845 2,2,2-trifluoroethyl cis-3- ((methylsulfonyl)amino)-2-(((1- (pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidine-1- carboxylate::US10287305, Example 286::US10287305, Example 305::US10508083, Example 305::US11292766, Example 305 Orexin receptor type 2 Homo sapiens 53.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386845&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310330 404855983 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771990 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)CC(F)(F)F InChI=1S/C22H31F3N2O4S/c1-32(29,30)26-19-8-5-13-27(21(28)14-22(23,24)25)20(19)15-31-18-11-9-17(10-12-18)16-6-3-2-4-7-16/h2-4,6-7,17-20,26H,5,8-15H2,1H3/t17-,18+,19-,20-/m0/s1 RWCKRWRHNFVBMQ-YRPNKDGESA-N 386860 N-((2R,3S)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)-1- (3,3,3- trifluoropropanoyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 306::US10508083, Example 306::US11292766, Example 306 Orexin receptor type 2 Homo sapiens 13.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386860&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310346 404855997 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771991 CC(C)OC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1C[C@H](C1)c1ccccc1 InChI=1S/C21H32N2O5S/c1-15(2)28-21(24)23-11-7-10-19(22-29(3,25)26)20(23)14-27-18-12-17(13-18)16-8-5-4-6-9-16/h4-6,8-9,15,17-20,22H,7,10-14H2,1-3H3/t17-,18+,19-,20-/m0/s1 BTPSMLCXKSIJDF-YRPNKDGESA-N 386861 US10287305, Example 307::US10508083, Example 307::US11292766, Example 307::isopropyl cis-3- ((methylsulfonyl)mino)-2-(((cis-3- phenylcyclobutyl)oxy)methyl)- piperidine-1-carboxylate Orexin receptor type 2 Homo sapiens 1600 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386861&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310347 404855998 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771992 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1C[C@H](C1)c1ccccc1)C(=O)CC1CC1 InChI=1S/C22H32N2O4S/c1-29(26,27)23-20-8-5-11-24(22(25)12-16-9-10-16)21(20)15-28-19-13-18(14-19)17-6-3-2-4-7-17/h2-4,6-7,16,18-21,23H,5,8-15H2,1H3/t18-,19+,20-,21-/m0/s1 CYRXZBCYGABWIJ-WOZUAGRISA-N 386862 N-(cis-1-(cyclopropylacetyl)-2- (((cis-3- phenylcyclobutyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 308::US10508083, Example 308::US11292766, Example 308 Orexin receptor type 2 Homo sapiens 590 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386862&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310349 404855999 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771993 COC(=O)N1CCC[C@H](NS(=O)(=O)N(C)C)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C22H35N3O5S/c1-24(2)31(27,28)23-20-10-7-15-25(22(26)29-3)21(20)16-30-19-13-11-18(12-14-19)17-8-5-4-6-9-17/h4-6,8-9,18-21,23H,7,10-16H2,1-3H3/t18-,19+,20-,21-/m0/s1 INDCLYIGPLPNIG-WOZUAGRISA-N 386863 US10287305, Example 309::US10508083, Example 309::US11292766, Example 309::methyl (2R,3S)-3- ((dimethylsulfamoyl)amino)-2- (((cis-4- phenylcyclohexyl)oxy)methyl)- piperidine-1-carboxylate Orexin receptor type 2 Homo sapiens 3.10 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386863&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310350 404856000 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771994 CN(C)S(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)C1CC1 InChI=1S/C24H37N3O4S/c1-26(2)32(29,30)25-22-9-6-16-27(24(28)20-10-11-20)23(22)17-31-21-14-12-19(13-15-21)18-7-4-3-5-8-18/h3-5,7-8,19-23,25H,6,9-17H2,1-2H3/t19-,21+,22-,23-/m0/s1 PCRLCJKQYKUKAH-MALNDZBISA-N 386864 N'-((2R,3S)-1- (cyclopropylcarbonyl)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)-N,N- dimethylsulfuric diamide::US10287305, Example 310::US10508083, Example 310::US11292766, Example 310 Orexin receptor type 2 Homo sapiens 2.20 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386864&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310354 404856001 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771995 CCc1ccccc1[C@@H]1CC[C@@H](CC1)OC[C@@H]1NCCC[C@@H]1NS(C)(=O)=O InChI=1S/C21H34N2O3S/c1-3-16-7-4-5-8-19(16)17-10-12-18(13-11-17)26-15-21-20(9-6-14-22-21)23-27(2,24)25/h4-5,7-8,17-18,20-23H,3,6,9-15H2,1-2H3/t17-,18+,20-,21-/m0/s1 JVHFPOYMKAKDAT-YHELAOLJSA-N 386865 N-(cis-2-(((cis-4-(2- ethylphenyl)cyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 311::US10508083, Example 311::US11292766, Example 311 Orexin receptor type 2 Homo sapiens 3200 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386865&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310356 404856002 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771996 CCc1ccccc1[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(C)=O)NS(C)(=O)=O InChI=1S/C23H36N2O4S/c1-4-18-8-5-6-9-21(18)19-11-13-20(14-12-19)29-16-23-22(24-30(3,27)28)10-7-15-25(23)17(2)26/h5-6,8-9,19-20,22-24H,4,7,10-16H2,1-3H3/t19-,20+,22-,23-/m0/s1 HCNCPJPEOMCLGO-MQFRRQCYSA-N 386866 N-((2R,3S)-1-acetyl-2-(((cis-4-(2- ethylphenyl)cyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 312::US10508083, Example 312::US11292766, Example 312 Orexin receptor type 2 Homo sapiens 32.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386866&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310352 404856003 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771997 CC(OC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCN(CC1)c1ncccn1)C(F)(F)F InChI=1S/C20H30F3N5O5S/c1-14(20(21,22)23)33-19(29)28-10-3-5-16(26-34(2,30)31)17(28)13-32-15-6-11-27(12-7-15)18-24-8-4-9-25-18/h4,8-9,14-17,26H,3,5-7,10-13H2,1-2H3/t14?,16-,17-/m0/s1 VGIILYNOQRNELS-HGVHAKBWSA-N 386867 1,1,1-trifluoropropan-2-yl cis-3- ((methylsulfonyl)amino)-2-(((1- (pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidine-1- carboxylate::US10287305, Example 313::US10508083, Example 313::US11292766, Example 313 Orexin receptor type 2 Homo sapiens 270 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386867&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310355 404856004 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771998 CN(C)S(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCN(CC1)c1ncccn1)C(=O)OCC(F)(F)F InChI=1S/C20H31F3N6O5S/c1-27(2)35(31,32)26-16-5-3-10-29(19(30)34-14-20(21,22)23)17(16)13-33-15-6-11-28(12-7-15)18-24-8-4-9-25-18/h4,8-9,15-17,26H,3,5-7,10-14H2,1-2H3/t16-,17-/m0/s1 JGZPMEOQRGKCIA-IRXDYDNUSA-N 386868 2,2,2-trifluoroethyl cis-3- ((dimethylsulfamoyl)amino)-2-(((1- (pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidine-1- carboxylate::US10287305, Example 315::US10508083, Example 315::US11292766, Example 315 Orexin receptor type 2 Homo sapiens 170 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386868&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310358 404856005 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 771999 CC(OC(=O)N1CCC[C@H](NS(=O)(=O)N(C)C)[C@@H]1COC1CCN(CC1)c1ncccn1)C(F)(F)F InChI=1S/C21H33F3N6O5S/c1-15(21(22,23)24)35-20(31)30-11-4-6-17(27-36(32,33)28(2)3)18(30)14-34-16-7-12-29(13-8-16)19-25-9-5-10-26-19/h5,9-10,15-18,27H,4,6-8,11-14H2,1-3H3/t15?,17-,18-/m0/s1 SXWILNQSEXQDEO-BEEDKBRMSA-N 386869 1,1,1-trifluoropropan-2-yl cis-3- ((dimethylsulfamoyl)amino)-2-(((1- (pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidine-1- carboxylate::US10287305, Example 316::US10508083, Example 316::US11292766, Example 316 Orexin receptor type 2 Homo sapiens 330 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386869&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310359 404856006 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772000 Cc1ccccc1[C@@H]1CC[C@@H](CC1)OC[C@@H]1NCCC[C@@H]1NS(C)(=O)=O InChI=1S/C20H32N2O3S/c1-15-6-3-4-7-18(15)16-9-11-17(12-10-16)25-14-20-19(8-5-13-21-20)22-26(2,23)24/h3-4,6-7,16-17,19-22H,5,8-14H2,1-2H3/t16-,17+,19-,20-/m0/s1 FAZZKRDKUCQYGV-HNJRGHQBSA-N 386870 N-((2R,3S)-2-(((cis-4-(2- methylphenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 318::US10508083, Example 318::US11292766, Example 318 Orexin receptor type 2 Homo sapiens 1100 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386870 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386870&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310365 404856007 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772001 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1C InChI=1S/C22H34N2O4S/c1-16-7-4-5-8-20(16)18-10-12-19(13-11-18)28-15-22-21(23-29(3,26)27)9-6-14-24(22)17(2)25/h4-5,7-8,18-19,21-23H,6,9-15H2,1-3H3/t18-,19+,21-,22-/m0/s1 QOVFZDUJXUASHY-MXNKGDRCSA-N 386871 N-((2R,3S)-1-acetyl-2-(((cis-4-(2- methylphenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 319::US10508083, Example 319::US11292766, Example 319 Orexin receptor type 2 Homo sapiens 29.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386871&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310362 404856008 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772002 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1C(F)F InChI=1S/C20H30F2N2O3S/c1-28(25,26)24-18-7-4-12-23-19(18)13-27-15-10-8-14(9-11-15)16-5-2-3-6-17(16)20(21)22/h2-3,5-6,14-15,18-20,23-24H,4,7-13H2,1H3/t14-,15+,18-,19-/m0/s1 LEKDNSMBQAJYFD-QXGSTGNESA-N 386872 N-((2R,3S)-2-(((cis-4-(2- (difluoromethyl)phenyl)cyclohexyl)- oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 320::US10508083, Example 320::US11292766, Example 320 Orexin receptor type 2 Homo sapiens 2000 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386872&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310360 404856009 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772003 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1c(C)cccc1C InChI=1S/C23H36N2O4S/c1-16-7-5-8-17(2)23(16)19-10-12-20(13-11-19)29-15-22-21(24-30(4,27)28)9-6-14-25(22)18(3)26/h5,7-8,19-22,24H,6,9-15H2,1-4H3/t19-,20+,21-,22-/m0/s1 UMUXIQOXSAUSGY-LRSLUSHPSA-N 386873 N-(cis-1-acetyl-2-(((cis-4-(2,6- dimethylphenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 321::US10508083, Example 321::US11292766, Example 321 Orexin receptor type 2 Homo sapiens 2200 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386873&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310361 404856010 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772004 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1C(F)F InChI=1S/C22H32F2N2O5S/c1-30-22(27)26-13-5-8-19(25-32(2,28)29)20(26)14-31-16-11-9-15(10-12-16)17-6-3-4-7-18(17)21(23)24/h3-4,6-7,15-16,19-21,25H,5,8-14H2,1-2H3/t15-,16+,19-,20-/m0/s1 YHXIAOBZMFWYQX-JSJNYSNDSA-N 386874 US10287305, Example 322::US10508083, Example 324::US11292766, Example 324::methyl cis-2-(((cis-4-(2- (difluoromethyl)phenyl)cyclohexyl)- oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 25.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386874&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310363 404856011 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772005 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1C(F)F InChI=1S/C22H32F2N2O4S/c1-15(27)26-13-5-8-20(25-31(2,28)29)21(26)14-30-17-11-9-16(10-12-17)18-6-3-4-7-19(18)22(23)24/h3-4,6-7,16-17,20-22,25H,5,8-14H2,1-2H3/t16-,17+,20-,21-/m0/s1 AYZCPSZIRGAGRW-JWWGGVBKSA-N 386875 N-((2R,3S)-1-acetyl-2-(((cis-4-(2- (difluoromethyl)phenyl)cyclohexyl)- oxy)methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 323::US10508083, Example 323::US11292766, Example 323 Orexin receptor type 2 Homo sapiens 96.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386875&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310364 404856012 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772006 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1C(F)F InChI=1S/C22H32F2N2O5S/c1-30-22(27)26-13-5-8-19(25-32(2,28)29)20(26)14-31-16-11-9-15(10-12-16)17-6-3-4-7-18(17)21(23)24/h3-4,6-7,15-16,19-21,25H,5,8-14H2,1-2H3/t15-,16+,19-,20-/m0/s1 YHXIAOBZMFWYQX-JSJNYSNDSA-N 386876 US10287305, Example 324::methyl (2R,3S)-2-(((cis-4-(2- (difluoromethyl)phenyl)cyclohexyl)- oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 8.00 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386876&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310363 404856013 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772007 CS(=O)(=O)N[C@H]1CCCN[C@H]1COC1CCC(F)(CC1)c1cc(F)cc(F)c1 InChI=1S/C19H27F3N2O3S/c1-28(25,26)24-17-3-2-8-23-18(17)12-27-16-4-6-19(22,7-5-16)13-9-14(20)11-15(21)10-13/h9-11,16-18,23-24H,2-8,12H2,1H3/t16?,17-,18-,19?/m0/s1 SUGNAYMHXOBIFT-YBXZHIRMSA-N 386877 N-(cis-2-(((4-(3,5-difluorophenyl)- 4-fluorocyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 325::US10508083, Example 325::US11292766, Example 325 Orexin receptor type 2 Homo sapiens 5000 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386877&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310366 404856014 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772008 CS(=O)(=O)N[C@H]1CCCN([C@H]1COC1CCC(F)(CC1)c1cc(F)cc(F)c1)C(=O)C1CC1 InChI=1S/C23H31F3N2O4S/c1-33(30,31)27-20-3-2-10-28(22(29)15-4-5-15)21(20)14-32-19-6-8-23(26,9-7-19)16-11-17(24)13-18(25)12-16/h11-13,15,19-21,27H,2-10,14H2,1H3/t19?,20-,21-,23?/m0/s1 YTLHBZZFQBPUMK-AZXFEVOCSA-N 386878 N-(cis-1-(cyclopropylcarbonyl)-2- (((4-(3,5-difluorophenyl)-4- fluorocyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 327::US10508083, Example 327::US11292766, Example 327 Orexin receptor type 2 Homo sapiens 2600 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386878&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310368 404856015 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772009 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ncccn1 InChI=1S/C19H30N4O4S/c1-14(24)23-12-3-5-17(22-28(2,25)26)18(23)13-27-16-8-6-15(7-9-16)19-20-10-4-11-21-19/h4,10-11,15-18,22H,3,5-9,12-13H2,1-2H3/t15-,16+,17-,18-/m0/s1 VHXFCBDDKCFOJW-MHORFTMASA-N 386879 N-(cis-1-(cyclopropylcarbonyl)-2- (((cis-4-(pyrimidin-2- yl)cyclohexyl)oxy)methyl)piperidin- 3-yl)methanesulfonamide::US10287305, Example 328 Orexin receptor type 2 Homo sapiens 7100 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386879&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310369 404856016 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772010 CC(C)OC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@@H]1CCN([C@H](C)C1)c1ncccn1 InChI=1S/C21H35N5O5S/c1-15(2)31-21(27)26-11-5-7-18(24-32(4,28)29)19(26)14-30-17-8-12-25(16(3)13-17)20-22-9-6-10-23-20/h6,9-10,15-19,24H,5,7-8,11-14H2,1-4H3/t16-,17-,18+,19+/m1/s1 JFFDDFDQEROSLJ-YRXWBPOGSA-N 386880 US10287305, Example 329::US10508083, Example 329::US11292766, Example 329::isopropyl cis-2-(((cis-2-methyl-1- (pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 22.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386880&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310370 404856017 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772011 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@](O)(CC1)c1ccccc1 InChI=1S/C21H32N2O6S/c1-28-20(24)23-14-6-9-18(22-30(2,26)27)19(23)15-29-17-10-12-21(25,13-11-17)16-7-4-3-5-8-16/h3-5,7-8,17-19,22,25H,6,9-15H2,1-2H3/t17-,18-,19-,21-/m0/s1 ORPIWJZHEDOATG-IWFBPKFRSA-N 386881 US10287305, Example 331::US10508083, Example 331::US11292766, Example 331::methyl cis-2-(((trans-4-hydroxy-4- phenylcyclohexyl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 1500 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386881&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310372 404856018 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772012 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1Cl InChI=1S/C19H29ClN2O3S/c1-26(23,24)22-18-7-4-12-21-19(18)13-25-15-10-8-14(9-11-15)16-5-2-3-6-17(16)20/h2-3,5-6,14-15,18-19,21-22H,4,7-13H2,1H3/t14-,15+,18-,19-/m0/s1 NSSAKDZKUZPKSW-QXGSTGNESA-N 386882 N-(cis-2-(((cis-4-(2- chlorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 332::US10508083, Example 332::US11292766, Example 332 Orexin receptor type 2 Homo sapiens 610 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386882&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310373 404856019 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772013 CS(=O)(=O)N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C19H30N2O3S/c1-25(22,23)21-18-8-5-13-20-19(18)14-24-17-11-9-16(10-12-17)15-6-3-2-4-7-15/h2-4,6-7,16-21H,5,8-14H2,1H3/t16-,17+,18-,19-/m0/s1 GWXIWAAZEKCXMJ-RDGPPVDQSA-N 386065 N-((2R,3S)-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 3::US10287305, Example 333::US10508083, Example 333::US11292766, Example 333 Orexin receptor type 2 Homo sapiens 340 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386065&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310078 404855224 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772014 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1Cl InChI=1S/C21H31ClN2O4S/c1-15(25)24-13-5-8-20(23-29(2,26)27)21(24)14-28-17-11-9-16(10-12-17)18-6-3-4-7-19(18)22/h3-4,6-7,16-17,20-21,23H,5,8-14H2,1-2H3/t16-,17+,20-,21-/m0/s1 ZMQPOZIUFUGYIW-JWWGGVBKSA-N 386884 N-(cis-1-acetyl-2-(((cis-4-(2- chlorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 334::US10508083, Example 334::US11292766, Example 334 Orexin receptor type 2 Homo sapiens 27.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386884&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310374 404856020 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772015 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1Cl InChI=1S/C21H31ClN2O5S/c1-28-21(25)24-13-5-8-19(23-30(2,26)27)20(24)14-29-16-11-9-15(10-12-16)17-6-3-4-7-18(17)22/h3-4,6-7,15-16,19-20,23H,5,8-14H2,1-2H3/t15-,16+,19-,20-/m0/s1 BBWOQHATGRUOTG-JSJNYSNDSA-N 386885 US10287305, Example 335::US10508083, Example 335::US11292766, Example 335::methyl cis-2-(((cis-4-(2- chlorophenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 6.10 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386885&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310376 404856021 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772016 CC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCC(C1)c1ccccc1 InChI=1S/C20H30N2O4S/c1-15(23)22-12-6-9-19(21-27(2,24)25)20(22)14-26-18-11-10-17(13-18)16-7-4-3-5-8-16/h3-5,7-8,17-21H,6,9-14H2,1-2H3/t17?,18?,19-,20-/m0/s1 HSUOLMXDGPQCJJ-GUMHCPJTSA-N 386886 N-(cis-1-acetyl-2-(((3- phenylcyclopentyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide::US10287305, Example 337::US10508083, Example 337::US11292766, Example 337 Orexin receptor type 2 Homo sapiens 2400 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386886&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310377 404856022 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772017 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCC(C1)c1ccccc1 InChI=1S/C20H30N2O5S/c1-26-20(23)22-12-6-9-18(21-28(2,24)25)19(22)14-27-17-11-10-16(13-17)15-7-4-3-5-8-15/h3-5,7-8,16-19,21H,6,9-14H2,1-2H3/t16?,17?,18-,19-/m0/s1 RIRPVRMHNIKWGG-BTRQGYIVSA-N 386887 US10287305, Example 338::US10508083, Example 338::US11292766, Example 338::methyl cis-3- ((methylsulfonyl)amino)-2-(((3- phenylcyclopentyl)oxy)methyl)- piperidine-1-carboxylate Orexin receptor type 2 Homo sapiens 490 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386887&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310378 404856023 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772018 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1COC1CCC(C1)c1ccccc1 InChI=1S/C21H33N3O4S/c1-3-22-21(25)24-13-7-10-19(23-29(2,26)27)20(24)15-28-18-12-11-17(14-18)16-8-5-4-6-9-16/h4-6,8-9,17-20,23H,3,7,10-15H2,1-2H3,(H,22,25)/t17?,18?,19-,20-/m0/s1 FSNHMVBYPDNWCI-GUMHCPJTSA-N 386888 US10287305, Example 339::US10508083, Example 339::US11292766, Example 339::cis-N-ethyl-3- ((methylsulfonyl)amino)-2-(((3- phenylcyclopentyl)oxy)methyl)- piperidine-1-carboxamide Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386888&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312512 404856024 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772019 CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1c(F)ccc(F)c1F)C(=O)CO InChI=1S/C21H29F3N2O5S/c1-32(29,30)25-17-3-2-10-26(19(28)11-27)18(17)12-31-14-6-4-13(5-7-14)20-15(22)8-9-16(23)21(20)24/h8-9,13-14,17-18,25,27H,2-7,10-12H2,1H3/t13-,14+,17-,18-/m0/s1 HRZYQXMNBPZWBV-DACLVMHWSA-N 386889 N-((2R,3S)-1-glycoloyl-2-(((cis-4- (2,3,6- trifluorophenyl)cyclohexyl)oxy)- methyl)piperidin-3- yl)methanesulfonamide::US10287305, Example 340::US10508083, Example 340::US11292766, Example 340 Orexin receptor type 2 Homo sapiens 2.50 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386889&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310379 404856025 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772020 CC(C)OC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@@H]1CCN(C[C@H]1F)c1ncccn1 InChI=1S/C20H32FN5O5S/c1-14(2)31-20(27)26-10-4-6-16(24-32(3,28)29)17(26)13-30-18-7-11-25(12-15(18)21)19-22-8-5-9-23-19/h5,8-9,14-18,24H,4,6-7,10-13H2,1-3H3/t15-,16+,17+,18-/m1/s1 ZKWLIYIFBPMANN-VSZNYVQBSA-N 386890 US10287305, Example 341::US10508083, Example 341::US11292766, Example 341::isopropyl cis-2-(((trans-3-fluoro- 1-(pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 13.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386890&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310381 404856026 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772021 CC(C)OC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CCN(C[C@H]1F)c1ncccn1 InChI=1S/C20H32FN5O5S/c1-14(2)31-20(27)26-10-4-6-16(24-32(3,28)29)17(26)13-30-18-7-11-25(12-15(18)21)19-22-8-5-9-23-19/h5,8-9,14-18,24H,4,6-7,10-13H2,1-3H3/t15-,16+,17+,18+/m1/s1 ZKWLIYIFBPMANN-OWSLCNJRSA-N 386891 US10287305, Example 342::US10508083, Example 342::US11292766, Example 342::isopropyl cis-2-(((cis-3-fluoro-1- (pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 30.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386891&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310383 404856027 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772022 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1cccc(O)c1 InChI=1S/C21H32N2O6S/c1-28-21(25)23-12-4-7-19(22-30(2,26)27)20(23)14-29-18-10-8-15(9-11-18)16-5-3-6-17(24)13-16/h3,5-6,13,15,18-20,22,24H,4,7-12,14H2,1-2H3/t15-,18+,19-,20-/m0/s1 GSFOETPYEBWTEI-LDTOTXGLSA-N 386892 US10287305, Example 343::US10508083, Example 343::US11292766, Example 343::methyl cis-2-(((cis-4-(3- hydroxyphenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 150 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386892&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310380 404856028 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772023 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccc(OC)cc1 InChI=1S/C22H34N2O6S/c1-28-18-10-6-16(7-11-18)17-8-12-19(13-9-17)30-15-21-20(23-31(3,26)27)5-4-14-24(21)22(25)29-2/h6-7,10-11,17,19-21,23H,4-5,8-9,12-15H2,1-3H3/t17-,19+,20-,21-/m0/s1 SQPYKRUZIIEHQK-NRDMVMEKSA-N 386893 US10287305, Example 344::US10508083, Example 344::US11292766, Example 344::methyl cis-2-(((cis-4-(4- methoxyphenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 290 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386893&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310386 404856029 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772024 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccc(O)cc1 InChI=1S/C21H32N2O6S/c1-28-21(25)23-13-3-4-19(22-30(2,26)27)20(23)14-29-18-11-7-16(8-12-18)15-5-9-17(24)10-6-15/h5-6,9-10,16,18-20,22,24H,3-4,7-8,11-14H2,1-2H3/t16-,18+,19-,20-/m0/s1 VWDXTDWYONBDOK-RNQOJCNYSA-N 386894 US10287305, Example 345::US10287305, Example 348::US10508083, Example 348::US11292766, Example 348::methyl cis-2-(((cis-4-(4- hydroxyphenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386894&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310385 404856030 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772025 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1O InChI=1S/C21H32N2O6S/c1-28-21(25)23-13-5-7-18(22-30(2,26)27)19(23)14-29-16-11-9-15(10-12-16)17-6-3-4-8-20(17)24/h3-4,6,8,15-16,18-19,22,24H,5,7,9-14H2,1-2H3/t15-,16+,18-,19-/m0/s1 XTPJJOICMJYISM-NBMJBFSESA-N 386895 US10287305, Example 347::US10508083, Example 347::US11292766, Example 347::methyl cis-2-(((cis-4-(2- hydroxyphenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 260 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386895&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310387 404856031 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772026 COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccc(O)cc1 InChI=1S/C21H32N2O6S/c1-28-21(25)23-13-3-4-19(22-30(2,26)27)20(23)14-29-18-11-7-16(8-12-18)15-5-9-17(24)10-6-15/h5-6,9-10,16,18-20,22,24H,3-4,7-8,11-14H2,1-2H3/t16-,18+,19-,20-/m0/s1 VWDXTDWYONBDOK-RNQOJCNYSA-N 386894 US10287305, Example 345::US10287305, Example 348::US10508083, Example 348::US11292766, Example 348::methyl cis-2-(((cis-4-(4- hydroxyphenyl)cyclohexyl)oxy)- methyl)-3- ((methylsulfonyl)amino)piperidine- 1-carboxylate Orexin receptor type 2 Homo sapiens 9.50 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386894&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310385 404856030 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772027 CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CCC[C@@H]1Oc1ccccc1 InChI=1S/C21H33N3O5S/c1-3-22-21(25)24-14-8-11-17(23-30(2,26)27)18(24)15-28-19-12-7-13-20(19)29-16-9-5-4-6-10-16/h4-6,9-10,17-20,23H,3,7-8,11-15H2,1-2H3,(H,22,25)/t17-,18-,19-,20-/m0/s1 BIUJTBRAKWHGKG-MUGJNUQGSA-N 386897 US10287305, Example 350::US10508083, Example 350::US11292766, Example 350::cis-N-ethyl-3- ((methylsulfonyl)amino)-2- ((((1S,2S)-2- phenoxycyclopentyl)oxy)methyl)- piperidine-1-carboxamide Orexin receptor type 2 Homo sapiens 1600 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386897&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312555 404856032 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772028 O=S(=O)(N[C@H]1CCCN[C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C1CC1 InChI=1S/C21H32N2O3S/c24-27(25,19-12-13-19)23-20-7-4-14-22-21(20)15-26-18-10-8-17(9-11-18)16-5-2-1-3-6-16/h1-3,5-6,17-23H,4,7-15H2/t17-,18+,20-,21-/m0/s1 QDVASRUBWHYCBT-YHELAOLJSA-N 386898 N-(cis-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3- yl)cyclopropanesulfonamide::US10287305, Example 353::US10508083, Example 353::US11292766, Example 353 Orexin receptor type 2 Homo sapiens 1300 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386898&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310388 404856033 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772029 CC(=O)N1CCC[C@H](NS(=O)(=O)C2CC2)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C23H34N2O4S/c1-17(26)25-15-5-8-22(24-30(27,28)21-13-14-21)23(25)16-29-20-11-9-19(10-12-20)18-6-3-2-4-7-18/h2-4,6-7,19-24H,5,8-16H2,1H3/t19-,20+,22-,23-/m0/s1 VNLWAUUOEOKWNM-MQFRRQCYSA-N 386899 N-(cis-1-acetyl-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3- yl)cyclopropanesulfonamide::US10287305, Example 354::US10508083, Example 354::US11292766, Example 354 Orexin receptor type 2 Homo sapiens 51.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386899&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310390 404856034 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772030 CCNC(=O)N1CCC[C@H](NS(=O)(=O)C2CC2)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C24H37N3O4S/c1-2-25-24(28)27-16-6-9-22(26-32(29,30)21-14-15-21)23(27)17-31-20-12-10-19(11-13-20)18-7-4-3-5-8-18/h3-5,7-8,19-23,26H,2,6,9-17H2,1H3,(H,25,28)/t19-,20+,22-,23-/m0/s1 MHHBNXDJGOSQGU-MQFRRQCYSA-N 386900 US10287305, Example 355::US10508083, Example 355::US11292766, Example 355::cis-3-((cyclopropylsulfonyl)amino)- N-ethyl-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidine-1-carboxamide Orexin receptor type 2 Homo sapiens 0.440 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386900&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312656 404856035 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772031 CC(C)OC(=O)N1CCC[C@H](NS(=O)(=O)C2CC2)[C@@H]1COC1CCN(CC1)c1ncccn1 InChI=1S/C22H35N5O5S/c1-16(2)32-22(28)27-12-3-5-19(25-33(29,30)18-6-7-18)20(27)15-31-17-8-13-26(14-9-17)21-23-10-4-11-24-21/h4,10-11,16-20,25H,3,5-9,12-15H2,1-2H3/t19-,20-/m0/s1 RCTGNFYIRGXOFA-PMACEKPBSA-N 386901 US10287305, Example 356::US10508083, Example 356::US11292766, Example 356::isopropyl cis-3- ((cyclopropylsulfonyl)amino)-2- (((1-(pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidine-1- carboxylate Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386901&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310391 404856036 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772032 CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(C)=O)NS(=O)(=O)C1CC1 InChI=1S/C20H36N2O4S/c1-14(2)16-6-8-17(9-7-16)26-13-20-19(5-4-12-22(20)15(3)23)21-27(24,25)18-10-11-18/h14,16-21H,4-13H2,1-3H3/t16-,17+,19-,20-/m0/s1 MVEAGSKWKBYCCV-HNJRGHQBSA-N 386902 N-(cis-1-acetyl-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)- piperidin-3- yl)cyclopropanesulfonamide::US10287305, Example 357::US10508083, Example 357::US11292766, Example 357 Orexin receptor type 2 Homo sapiens 84.0 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386902&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310393 404856037 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772033 CNC(=O)N1CCC[C@H](NS(=O)(=O)C2CC2)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1 InChI=1S/C23H35N3O4S/c1-24-23(27)26-15-5-8-21(25-31(28,29)20-13-14-20)22(26)16-30-19-11-9-18(10-12-19)17-6-3-2-4-7-17/h2-4,6-7,18-22,25H,5,8-16H2,1H3,(H,24,27)/t18-,19+,21-,22-/m0/s1 OSCKDKJFUHEURE-MXNKGDRCSA-N 386903 US10287305, Example 359::US10508083, Example 359::US11292766, Example 359::cis-3-((cyclopropylsulfonyl)amino)- N-methyl-2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidine-1-carboxamide Orexin receptor type 2 Homo sapiens 1.10 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386903&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130312561 404856038 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772034 FC(F)(F)COC(=O)N1CCC[C@H](NS(=O)(=O)C2CC2)[C@@H]1COC1CCN(CC1)c1ncccn1 InChI=1S/C21H30F3N5O5S/c22-21(23,24)14-34-20(30)29-10-1-3-17(27-35(31,32)16-4-5-16)18(29)13-33-15-6-11-28(12-7-15)19-25-8-2-9-26-19/h2,8-9,15-18,27H,1,3-7,10-14H2/t17-,18-/m0/s1 XUTDZCBPBXGAEP-ROUUACIJSA-N 386904 2,2,2-trifluoroethyl cis-3- ((cyclopropylsulfonyl)amino)-2- (((1-(pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidine-1- carboxylate::US10287305, Example 360::US10508083, Example 360::US11292766, Example 360 Orexin receptor type 2 Homo sapiens 210 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386904&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310394 404856039 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 772035 CC(OC(=O)N1CCC[C@H](NS(=O)(=O)C2CC2)[C@@H]1COC1CCN(CC1)c1ncccn1)C(F)(F)F InChI=1S/C22H32F3N5O5S/c1-15(22(23,24)25)35-21(31)30-11-2-4-18(28-36(32,33)17-5-6-17)19(30)14-34-16-7-12-29(13-8-16)20-26-9-3-10-27-20/h3,9-10,15-19,28H,2,4-8,11-14H2,1H3/t15?,18-,19-/m0/s1 VVVKNZDUXPGDTB-IROOXBOJSA-N 386905 1,1,1-trifluoropropan-2-yl cis-3- ((cyclopropylsulfonyl)amino)-2- (((1-(pyrimidin-2-yl)piperidin-4- yl)oxy)methyl)piperidine-1- carboxylate::US10287305, Example 362::US10508083, Example 362::US11292766, Example 362 Orexin receptor type 2 Homo sapiens 390 US Patent 10.7270/Q2Z321Z2 aid1798665 US10287305 Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T 5/14/2019 2/27/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386905&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130310398 404856040 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0